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SUMMARY
1. By mutagenesis, a strain of Escherichia coli is created that produces a 
citrate synthase with markedly different properties when compared with the 
wild type enzyme.
2. The citrate synthase gene, gltA, from this mutant organism is cloned and 
sequenced together with the gliA gene from its parent organism and a 
wild-type strain of E.coii. Sequence analysis reveals a single point mutation 
within the mutant gftA and the same base substitution is observed in the gllA 
gene of the parent organism. The implications of this substitution are 
discussed.
3. A polyclonal antibody is raised against the wild-type E.coii citrate 
synthase and shows no cross-reactivity with the mutant citrate synthase.
4. The mutant enzyme is purified to near homogeneity and the N-terminus is 
sequenced. Comparison with protein-data banks does not reveal any 
homologous proteins. The possible identity of the mutant protein is 
discussed.
1. INTRODUCTION
1.1 Role of Citrate Svnthase in the Citric Acid Cycle
Although the idea of a cyclic pathway as the terminal stage of cellular 
respiration in animals was proposed by Krebs and Johnson in 1937, it was 
not until 1950 that the last piece of the puzzle, namely the formation of citrate 
from oxaloacetate (OAA) and pyruvate, was solved. Stern and colleagues 
(1950) showed that ’active acetate’, later identified as acetyl-CoA (Lynen & 
Reichert, 1951), was formed from pyruvate and that this combined with OAA 
by the action of ’condensing enzyme’, now known as citrate synthase [EC 
4.1.3.7], to form citrate:
oxaloacetate + acetyl CoA + H2O -> citrate + CoASH + H+
The citric acid cycle, shown in Fig. 1.1, is the final stage of oxidation of 
all major foodstuffs in the vast majority of living organisms and has a dual 
function in being responsible for the production of both energy, as ATP, and 
the biosynthetic precursors for cell components (Krebs etal., 1952; Roberts 
etai, 1953)
Citrate synthase (CS) is often regarded as the ’first’ enzyme in the 
citric acid cycle, as it is by the formation of citrate that carbon atoms enter the 
cycle to be oxidised to CO2 and to form reducing equivalents. Indeed CS is 
the only enzyme in the citric acid cycle that is involved in the formation of 
carbon-carbon bonds. CS is responsible for supplying carbon atoms to the 
cycle and has been proposed as the key regulating enzyme of the pathway, 
since intermediates of the cycle do not accumulate (Krebs & Lowenstein, 
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Fig. 1.1. The Citric Add Cyde
4computer simulation of control of the citric acid cycle in rat heart (McMinn & 
Ottaway, 1976).
In eukaryotic cells CS occurs almost exclusively in the mitochondria, 
although both a mitochondrial and a peroxisomal form of the enzyme have 
been identified in yeast (Duntze etal., 1969; Wales et al., 1980) and, in 
germinating plants, CS is found in both the mitochondria and the 
glyoxysomes (Breidenbach & Beevers, 1967; Cooper & Beevers, 1969).
1.2 Oligomeric Structure
The central role of CS in metabolism has, therefore, generated much 
interest and consequently, CS has been purified from a great number of 
sources, though the pig heart and E.coii forms of the enzyme have been the 
most extensively studied. The amino acid sequences of CS have been 
determined directly from pig kidney (Evans et al., 1988) and heart (Bloxham 
etal., 1982) and E.coii (Bhayana & Duckworth, 1984) and inferred from 
DNA sequences of the gene encoding the enzyme, from pig heart (Bloxham 
eta/., 1981), the Gram-negative organisms E.coii, (Guest, 1981; Ner etal., 
1983), Pseudomonas aeruginosa (Donald etal., 1989), Acinetobacter 
anitritum (Donald & Duckworth, 1987) and Acetobacteraceti (Fukaya etal., 
1990) the yeast Saccharomyces cerevisiae (Suissa et al., 1984), the 
parasitic bacterium Rickettsiaprowazekii (Wood etal., 1987), the plant 
Arabidopsis thaliana (Ungar et al., 1989), and the archaebacterium 
Thermoplasma acidophilum (Sutherland et a!., 1990).
Multiple alignment of these sequences (Sutherland et al., 1990) has 
shown high sequence identity between the eukaryotic and plant enzymes 
(48-60%) with an even higher identity existing between the members of 
Gram-negative bacteria (57-70%).
5The pig and chicken heart CSs have been analysed by X-ray 
crystallography (Remington etal., 1982; Wiegand etal., 1984) revealing that 
the 437 amino acid residues of each subunit of the pig heart enzyme are 
arranged as 20 a-helices and a small segment of p-sheet. The crystal 
stucture of CS from E.coii has also been determined, but only at low 
resolution (Rubin etal., 1983). Using sequence alignment data for pig heart 
and E.coii CSs, Henneke has generated, by molecular modelling, a three 
dimensional structure for the monomeric unit of E.coii CS (Henneke, C.M. et 
al., unpublished data).
1.3 Regulation
1.3.1 Isosteric Inhibition bv Nucleotides
When Hathaway and Atkinson demonstrated in 1965 that CS from 
yeast was inhibited in vitro by ATP, it was postulated that this was a 
physiological feedback mechanism, as CS is the 'first* enzyme in an ATP 
producing cycle. ATP was shown to be most effective as an inhibitor when 
concentrations of ADP .and AMP were low, leading Atkinson (1968) to 
develop the concept of energy charge, in which the relative rather than 
absolute concentrations of the three nucleotides are of metabolic 
importance.
Since then, a similar inhibition of CSs from a variety of organisms has 
been demonstrated (Weitzman & Danson, 1976). However, the effect is 
reduced in the presence of low concentrations (1.5 mM) of Mg2+ ions 
(Kosicki & Lee, 1966) and in in situ studies on permeabilised yeast cells 
(Weitzman & Hewson, 1973) and rat liver mitochondria (Matlib etal., 1978). 
Moreover, ATP inhibition of CS has been demonstrated in organisms in 
which the citric acid cycle plays a biosynthetic rather than an energy
6Therefore, the suggestion that ATP acts as an in vivo regulator of CS is 
questionable. Nevertheless, the inhibition of the enzyme by ATP has been 
shown to be competitive with respect to acetyl-CoA (Harford & Weitzman, 
1975; Weitzman, 1981) and as they are structurally similar it has been 
suggested that they bind at the same site (Kosicki & Lee, 1966; Srere et al., 
1973; Harford & Weitzman, 1975).
Nicotinamide nucleotides have also been shown to act as weak 
inhibitors of ATP sensitive CSs (Lee & Kosicki, 1967). Like ATP they share 
structural similarities with acetyl-CoA and have been shown to compete for 
the same site on the enzyme (Weitzman, 1981).
1.3.2 Allosteric Inhibition bv NADH
In contrast to ATP, NADH, also an ’end product’ of the cycle, has 
gained more favour as a specific feedback regulator of CS. The E.coii 
enzyme, although only weakly inhibited by ATP, is very sensitive to NADH 
and is inhibited in an allosteric manner (Weitzman, 1966a; Faloona & Srere, 
1969). This inhibition is specific to NADH as no other nucleotides inhibit 
E.coii CS. Other Gram-negative bacterial CSs were studied and these too 
were inhibited specifically by NADH (Weitzman & Jones, 1968). Conversely, 
eukaryotes and Gram-positive bacteria were shown to produce CSs that 
were unaffected by NADH. Moreover, the Gram-negative bacteria could be 
further divided into two groups, as the NADH inhibition of some (e.g. 
A.calcoaceticus) was reversed by AMP. Further examination revealed that 
these were strictly aerobic bacteria. These organisms rely solely on the citric 
acid cycle for energy production and, therefore, it makes sense for AMP, an 
indicator of low energy levels, to regulate a key enzyme in the cycle.
71.3.3 Biosynthetic Control
As the citric acid cycle is responsible not only for the production of 
energy but also for the production of biosynthetic precursors, it would seem 
appropriate that these substances also exert some regulatory control on CS. 
2-oxoglutarate and succinyl-CoA, both produced by the citric acid cycle, are 
used for amino acid and porphyrin biosynthesis respectively and have been 
reported to inhibit CSs from certain organisms.
(i) Inhibition bv 2-oxoalutarate
The inhibition of CS by 2-oxoglutarate was first reported by Wright et 
at. (1967). This prompted Weitzman and Dunmore (1969) to examine a 
range of organisms and they found that only CSs from facultatively 
anaerobic Gram-negative bacteria were inhibited by 2-oxoglutarate, 
whereas aerobic Gram-negative bacteria, Gram-positive bacteria and 
eukaryotes were unaffected. This is most likely due to the fact that facultative 
anaerobes can produce energy by carbohydrate fermentation and under 
such conditions the enzyme 2-oxoglutarate dehydrogenase is absent. Thus, 
a branched non-cyclic pathway operates to provide the biosynthetic 
precursors 2-oxoglutarate and succinyl-CoA (Amarasingham & Davis, 1965) 
(Fig. 1.2). Further investigations of facultatively autotrophic Thiobacilli sp. 
(Taylor, 1970), Gram-positive facultative anaerobes (Gottschalk& 
Dittbrenner, 1970) and strict anaerobes (Tanaka & Hanson, 1975) have 
revealed that inhibition by 2-oxoglutarate is not restricted to Gram-negative 
facultative anaerobes, but is a feature of all bacteria that lack 2-oxoglutarate 
dehydrogenase and hence have 2-oxoglutarate as a biosynthetic end 
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Fig. 1.2. Branched Non-cyclic Pathway Operating in Facultative Anaerobes
9ii) Inhibition bv 2-oxoalutarate and Succinvl-CoA
An additional feedback control mechanism is found in the Gram- 
negative cyanobacteria. Like facultative anaerobes, cyanobacteria lack 2- 
oxogiutarate dehydrogenase and do not use the citric acid cycle for energy 
production. Therefore, their CSs are inhibited by 2-oxoglutarate (Lucas & 
Weitzman, 1977) but not by NADH (Taylor, 1973) However, unlike the 
situation in E.coii, succinyl-CoA is also formed from citrate via the glyoxylate 
cycle (Pearce etal., 1969) (Fig. 1.3). Succinyl-CoA is, therefore, an end 
product of the initial reaction catalysed by CS in cyanobacteria and has 
been found, in addition to 2-oxoglutarate, to inhibit CS in these organisms 
(Lucas & Weitzman, 1977). This inhibition by succinyl-CoA is specific to 
cyanobacteria and would appear to reflect the unique metabolic pathway 
displayed by these organisms.
1.4 Molecular Size
An examination by Weitzman and Dunmore (1969) of the enzyme 
from a variety of sources revealed that CSs can be divided into two groups 
according to their molecular sizes. Those of eukaryotes and Gram-positive 
bacteria are termed ’small’, having a Mr~100 000, whilst Gram-negative 
bacteria produce a ’large’ enzyme of Mr -250 000. Additional CSs have 
subsequently been analysed and these studies have further confirmed this 
distribution of molecular sizes.
The ’small’ enzyme was shown to be a dimer of identical subunits of 
M r 50 000 in eukaryotes (Srere, 1972) and was later, also shown to be the
case in Gram-positive bacteria (Weitzman & Danson, 1976) and 
Archaebacteria (Danson et al., 1985). The elucidation of the subunit 














Fig. 1.3. The Glyoxylate Cycle
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Originally, it was reported that the enzyme from E.coii was a tetramer 
(Wright & Sanwal, 1971), each subunit being identical and having a 
M r6 2  000. Later work by Tong and Duckworth (1975), using a combination
of equilibrium ultracentrifugation and cross-linking with dimethyl 
suberimidate followed by SDS PAGE, showed the E.coii enzyme to be a 
hexamer of subunit M r4 7 000. A predominance of even-numbered species
on analysis of the cross-linked enzyme, together with ultracentrifugation 
results showing that a dimer is the only species present in dilute buffer at pH 
9.0 and is one of two species present in 50 mM KCI, indicated that a dimeric 
arrangement of the subunits of the E.coii enzyme is exceptionally stable and 
may be equivalent to the eukaryotic enzyme. Proteolysis studies of CS from 
E.coii (Else etal., 1988) and A.calcoaceticus (Mitchell & Weitzman, 1983) 
have indicated that the hexameric structure is arranged as a trimer of dimers. 
Thus, the dimer is the basic catalytic unit of the enzyme from eukaryotes, 
Archaebacteria, Gram-positive and Gram-negative bacteria.
1.5 Correlation of Oligomeric Properties and Regulatory Sensitivities
In summary, a pattern of diversity exists with respect to molecular size 
and regulatory function of CS. Eukaryotic and Gram-positive bacterial CSs 
are ’small’ dimeric proteins, whereas Gram-negative bacterial CS is a ’large’ 
hexameric protein. The two proteins differ not only in size but are also 
regulated by different effectors. The ’small’ proteins are probably regulated 
isosterically by ATP and the ’large’ protein allosterically by NADH. Inhibition 
of CS by NADH is specific and is reversed by AMP in strictly aerobic 
organisms. In addition, CSs from facultative anaerobes are inhibited by 2- 
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Table 1.1. Diversity of CSs
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1.6 Exceptions and Extensions to the Pattern of Enzyme Diversity
Although the majority of CSs studied so far follow the pattern above, 
there are some, nevertheless, that do not. Several Gram-negative bacteria 
have been identified that produce CSs that although characteristically of the 
’large’ type are insensitive to NADH (Swissa & Benziman, 1976; Weitzman, 
1981).
In addition, Phibbs and Winkler (1982) have reported that the enzyme 
from the Gram-negative intracellular parasite R.prowazekii has unusual 
characteristics being of the ’small’ type enzyme but not inhibited by ATP.
This review has concentrated on eukaryotic and eubacterial CSs yet 
a third group of organisms have been identified: the Archaebacteria (Olsen 
& Woese, 1989). Although only a handful have been studied so far, they 
have all been shown to produce ’small’ NADH insensitive CSs (Cazzulo, 
1973; Danson etal., 1985: Sutherland etal., 1990).These organisms are 
generally found in extreme environments such as high temperature and high 
salt concentrations and it may be that the dimer is more able to maintain its 
native structure than the ’large’ hexameric form under these disruptive 
conditions. Moreover, inhibition of eubacterial CS by NADH has been 
shown to be lost in increased salt concentrations (Weitzman, 1966b; 
Massarini etal., 1976) and, therefore, this regulatory function would be 
ineffective in the organisms natural environment.
1.7 Multiple Forms of the Enzvme
Whilst the majority of organisms contain only one form of CS a few 
organisms have been identified that produce multiple forms of the enzyme. 
Mitochondrial and glyoxysomal CSs have been isolated in plants 
(Breidenbach & Beevers, 1967; Cooper & Beevers, 1969) and both a
14
mitochondrial and a peroxisomal enzyme have been found in the yeast
S.cerevisiae (Duntze etal., 1969; Wales etal., 1980). In both cases the 
enzymes appear to be all of the 'small' type. The plant enzymes display 
different kinetic properties (Axelrod & Beevers, 1972; Barbareschi etal., 
1974) and can be separated by chromatography (Barbareschi etal., 1974). 
Yet despite these differences both the glyoxisomal and mitochondrial CSs 
cross-react with anti-glyoxisomal CS antibodies (Huang etal. 1974). The 
two yeast enzymes are encoded by distinct but highly homologous (75% 
identity) genes (Kim etal., 1986; Rickey & Lewin, 1986; Rosenkrantz etal.,
1986) but unlike the plant enzymes, antibodies raised against yeast 
mitochondrial CS do not cross-react with the peroxisomal form (Rickey & 
Lewin, 1986) although there is a high degree of homology in their amino 
acid sequences. It has been proposed that the enzymes also differ in their 
metabolic function: the non-mitochondrial forms participating in the 
glyoxylate cycle (Breidenbach & Beevers, 1967; Cooper & Beevers, 1969; 
Kispal et al., 1989; Lewin etal., 1990).
Whereas these CSs are all of one type, a different situation has been 
found in various Pseudomonas species. It has been reported that these 
species possess two types of CS: a 'large' NADH sensitive enzyme and a 
'small' NADH insensitive enzyme (Solomon & Weitzman, 1983; Mitchell & 
Weitzman, 1986). The relative proportions of each vary with the phase of 
growth of the organism (Solomon & Weitzman, 1983). The two enzymes do 
not interconvert and so, unlike previous studies (Massarini & Cazzulo, 1975; 
Higa et al., 1978), are not different forms of the same enzyme. However, a 
recent study observed only the 'large' NADH sensitive form, as judged by 




Kinetic and binding studies have established that CS acts by an 
ordered mechanism involving the formation of a two substrate ternary 
complex (Shepherd & Garland, 1969; Johansson et a!., 1973; Matsuoka & 
Srere, 1973). Oxaloacetate binds first, increasing the binding constant for 
acetyl-CoA by at least 20 fold (Johansson & Petersson, 1974). Binary 
complex formation with acetyl-CoA has also been shown to take place at 
high acetyl-CoA concentrations but this substantially decreases the on-rate 
for OAA, indicating substrate inhibition (Johansson & Petersson, 1977). The 
rate-limiting step during catalysis appears to be the conversion of the ternary 
enzymesubstrate complex into a ternary enzymeproduct complex (Bov6 et 
aI., 1959; Kosicki & Srere, 1961).
CS is highly specific towards its substrates as only acetyl-CoA (Stern 
etal., 1951), fluoroacetyl-CoA (Brady, 1955), OAA (Stern etal., 1951) and 
fluorooxaloacetate (Fanshier etal., 1964) have been shown to be substrates 
for the condensation reaction, although a number of acetyl-CoA analogues 
have been shown to bind to the enzyme (Chase et al., 1966; Stern, 1961; 
Weidman etal., 1971).
Citryl-CoA was shown to inhibit eukaryotic CS (Srere & Kosicki,
1963), and it was postulated that citryl-CoA was an intermediate of the 
reaction. Eggerer and Remberger (1963) were the first to show that citryl- 
CoA could indeed be hydrolysed by the enzyme, a result that was later 
confirmed by Srere (1963) and more recently by Pettersson (Pettersson et 
al., 1989).
The stereochemistry of the reaction catalysed by CS has been 
elucidated showing that the acetyl group of acetyl-CoA adds to the si-face of 
the keto moiety of OAA (Bove etal., 1959; Englard, 1959; Hanson & Rose,
16
1963) with a concomitant inversion of the configuration of the methyl 
hydrogens (Eggerer et a/., 1970; Ret6y etal., 1970; Klinman & Rose, 1971; 
Lenz etal., 1971).
The overall reaction (Eggerer, 1965) can be divided into three partial 
reactions, namely i) generation of a carbanion on acetyl-CoA by removal of 
a proton, ii) nucleophillic attack of the carbanion form of acetyl-CoA to form 
citryl-CoA and iii) hydrolysis of citryl-CoA to produce citrate and CoA.
1.9 Conformational Changes During Catalysis
Early studies using uv spectra, kinetics and spin labels provided a 
wealth of information suggesting that a change in conformation of CS 
occurred on binding its substrates (Srere,1966; Rowe & Weitzman, 1969; 
Weidman eta/., 1973; Johansson & Pettersson, 1979; Bayer etal., 1981).
Crystal structure analysis has also provided considerable insight into 
the structural and functional properties of the enzyme. Remington 
(Remington etal., 1982) observed two forms of the enzyme from pig heart, a 
closed (monoclinic) crystal in the presence of citrate and CoA and an open 
(tetragonal) crystal representing the free enzyme. Each subunit was shown 
to be composed of a large and a small domain connected by a ’hinge’ 
region. The two subunits were shown to be extensively interdigitated with 
residues from one subunit contributing to the active site of the other. Thus, 
the two subunits are dependent on each other for complete catalytic activity 
and would, therefore, explain the importance of the dimeric unit as 
previously described (1.2). The active site was shown to lie in a deep cleft 
between the two domains of each subunit and it was proposed that binding 
of OAA induces the change in conformation from the open to closed form, 
bringing about a change in configuration of active site residues (Lesk &
17
Chothia, 1984) in order that catalysis may proceed. Wiegand etal. (1984) 
described a third crystal structure of the pig heart enzyme in the presence of 
OAA and S-acetonyl-CoA (a potent inhibitor of CS). This third form was 
described as ’nearly closed’ with considerable re-arrangement within the 
domains compared with the two previously described forms. Wiegand and 
Remington (1986) proposed that OAA binds to the open form of the enzyme 
inducing the closed (or nearly closed) form. This form polarises and 
orientates OAA and provides a binding site for acetyl-CoA. As acetyl-CoA 
enters the active site a proton is removed from the methyl group and 
condensation occurs, resulting in the inversion of the configuration of the 
hydrogens of the methyl group. The appearance of citryl-CoA on the enzyme 
induces the closed form and subsequent hydrolysis releases the products 
citrate and CoA. Thus, the nearly closed form and closed form might reflect 
the different catalytic states of the enzyme, namely, condensation and 
hydrolysis (Bayer etal., 1981; Lohlein-Werhahn etal., 1983; Lill etal., 1984; 
Lill etal., 1987; Lohlein-Werhahn etal., 1988). However, this has recently 
been questioned by studies using fluorescent probes (Kollman-Koch & 
Eggerer, 1989) and crystallography (Karpusas etal., 1990, Karpusas etal., 
1991: Liao etal., 1991). Karpusas (Karpusas etal., 1990) has crystallised a 
ternary enzyme OAAcarboxymethyl-CoA complex, refined at 1.9 A, from 
chicken heart that they suggest is capable of catalysing the whole reaction 
and have shown that L-malate, a structural analogue of OAA, binds to the 
closed conformation (Karpusas etal., 1991). Recently Liao etal. (1991) 
have suggested that the closed and open forms are in equilibrium in solution 
and that if ligands with large binding constant are present then the 
equilibrium is driven towards the closed conformation.
18
1.10 Catalytic Mechanism
Early work investigating the residues responsible for catalysis made 
use of a variety of chemical modifiers, although the majority of work has 
concentrated on sulphydryl modifiers such as DTNB, iodoacetate and 2- 
nitro-5-thiobenzoic acid. Modification of sulphydryl groups produced 
different responses from organism to organism. CSs from eukaryotes have 
generally been shown to be totally insensitive to sulphydryl modification 
(Srere et a!., 1963; Srere, 1965; Weitzman & Danson, 1976). Some plants 
have been shown to be sensitive to sulphydryl modification (Srere etal., 
1971; Greenblatt & Sarkissian, 1973) whereas others have been shown to 
be totally insensitive (Srere etal., 1971). The same diversity of response 
was observed in CSs from Gram-positive and Gram-negative bacteria 
(Dittbrenner etal., 1969; O’Brien & Stern; 1969; Danson & Weitzman, 1973; 
Weitzman & Danson, 1976; Danson & Weitzman, 1977; Talgoy & Duckworth, 
1979). However, in Gram-negative bacteria where inactivation of the 
enzyme by sulphydryl modification was observed there was also a 
desensitisation of the enzyme to NADH. This implied that cysteine residues 
are involved in this regulatory function. This cysteine residue has recently 
been identified as Cys 206 in E.coli which is located near the interface 
between the two subunit domains (Duckworth et at., 1987) and may be 
essential in allowing the necessary movement of the domains to orientate 
the active site. Likewise the binding of NADH to a sulphydryl group in this 
position would interfere with the movement of the two domains thus 
preventing catalysis and would explain the inhibitory effect of NADH. 
Examination of the nucleotide sequences published to date, reveals that in 
those organisms sensitive to sulphydryl modification, a cysteine residue is 
present at the equivalent position (Table 1.2).
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Photo-oxidation studies have also been used to study the catalytic 
mechanism of CS and have implicated the importance of several amino 
acids. Histidine residues were suggested as being involved in the enzymatic 
activity and the inhibition by 2-oxoglutarate (Danson & Weitzman, 1973; 
Weitzman etal., 1974; M&hlen, 1975; Weitzman & Danson, 1976). Arginine 
and tryptophan residues (Danson & Weitzman, 1973; M&hlen, 1975; 
Weitzman & Danson, 1976) also appear to play some part in catalysis. 
Furthermore, using proteolysis Bloxham and colleagues (1980) proposed 
that the binding site for OAA and citrate was in a region corresponding to 
residues 336-337.
Crystallographic studies of the enzyme from pig heart and chicken 
heart have verified these findings, showing that indeed three histidine (238, 
274, 320) and three arginine residues (329, 401, 421) are in contact with 
citrate and OAA and three arginine residues (46, 164, 324) and one lysine 
residue (368) form salt bridges with CoA at the active site (Remington et al.t 
1982; Wiegand etal., 1984; Karpusas etal., 1990; Karpusas etal., 1991). 
The majority of nucleotide sequences analysed so far have all these 
residues conserved in equivalent positions although Arg 46 and Arg 164 are 
less well conserved in Gram-negative organisms (Ner etal., 1983; Donald & 
Duckworth, 1987; Wood etal., 1987) (Table 1.2). It has been suggested (Ner 
et al., 1983) that lack of these residues is associated with a high Km for 
acetyl-CoA, but this has been questioned by Wood (Wood et al., 1987) as 
R.prowazekii possesses neither residue yet has a Km for acetyl-CoA 
equivalent to that of pig heart.
Three amino acids were identified as being potential key residues in 
catalysis: His 274, His 320 and Asp 375 and these have been shown, by 
multiple alignment, to be conserved throughout all CS sequences analysed
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so far (Donald etal., 1989; Henneke etal., 1989; Unger etal., 1989; 
Sutherland etal., 1990) (Table 1.2). It has been proposed (Remington etal., 
1982; Karpusas etal., 1990) that His 274 and Asp 375 act as proton 
acceptors and donors to the acetyl and methyl groups of acetyl-CoA whilst 
His 320 is in an ideal position to protonate the carbonyl oxygen of OAA. It 
has also been suggested that Asp 375 protonates the intermediate citryl- 
CoA causing the release of CoA (Fig. 1.4).
Site directed mutagenesis has further helped to identify the residues 
important for ligand binding and catalysis. Changing His 229 of E.coli CS 
(equivalent to His 238 of pig heart) or His 226 of E.coli CS to Glu resulted in 
a reduced affinity for OAA and 2-oxoglutarate which was more pronounced 
for the His 229 mutation (Anderson & Duckworth, 1988), confirming the 
proposal that this is one of the substrate binding sites (Remington etal.,
1982). Evans etal. (1989) and Alter etal. (1990) have clearly shown that 
changing Asp 375 of pig heart CS to amino acids that do not have a 
dissociable proton (i.e Asn, Gin, and Gly) renders the enzyme virtually 
inactive. Handford et al. (1988) showed a similar inactivation when Asp 362 
of E.coli CS (equivalent to Asp 375 of pig heart CS) was replaced with Gly. 
Asp 362 was shown to be essential not only for catalysis but also for the 
binding of acetyl-CoA but not OAA. In addition replacing His 274 of pig heart 
CS with Gly or Arg (Evans etal., 1989; Alter etal., 1990) also reduced the 
enzyme’s activity. These results are summarised in Table 1.3.
1.11 Mutant Forms of Citrate Svnthase
Chemical modification, X-ray crystallography and site directed 
mutagenesis have provided us with a considerable insight into the structure 
and regulatory properties of CSs. However, there is still virtually nothing
ligand bound in 
crystal structure
Pig Heart E.coli A.anitratum P.aeruginosa S.cerevisiae 
1 2
T.acidophilum R.prowasekii A.thaliana
arg 329 314 315 314 368 348 271 319 359
arg 401 387 388 387 440 420 344 394 429
arg 421 407 408 407 460 440 364 415 449
Citrate his 238 229 226 229 277 254 187 234 268
his 274 264 267 264 222 269 304
his 320 305 306 305 313 393 262 310 350
asp 375 362 363 362 414 394 317 369 403
CoA 3-phosphate arg 164 157 159 157 184 121 - lys 235
arg 46 - - - 86 66 lys 8 - arg 84
CoA 5’-diphosphate arg 324 Iys309 Iys310 Iys309 363 343 lys 266 Iys314 arg 354
Me3lys 368 Iys356 arg356 arg355 407 387 Iys363 arg 396
NADH - cys206 ala208 cys206 Iys255 235cys cys211
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Fig. 1.4. Proposed Mechanism of Citrate Synthase Reaction
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Table 1.3. Site directed Mutagenesis of CS
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known regarding subunit interactions of the enzyme and how these 
interactions effect the regulation of the enzyme, bearing in mind that only 
’large’ hexameric CSs are regulated by NADH. Bacterial mutants deficient in 
CS have been used in many studies to investigate the physiological role of 
the enzyme (Gilvarg & Davis, 1956; Ashworth etal., 1965; Carls & Hanson, 
1971; Lakshmi & Helling, 1976; Beatty et al., 1977) and this mutant 
approach has been used to provide a tool crucial to the attempt to answer 
these questions regarding subunit interactions. The aim has been to isolate 
mutant organisms producing variant forms of CS with altered structure and 
regulation. Investigation of such mutant enzymes may provide information 
on molecular requirements for the different subunit arrangements and 
regulatory effectors observed in CSs from various sources.
The strategy used for obtaining mutant forms of the enzyme has been 
first to produce a CS deficient mutant, to mutate that organism and then to 
select revertants that have regained CS activity. The regaining of activity 
would in some cases be a result of second site mutations within the gene 
leading to the production of a CS with a slightly altered amino acid 
composition from the parent organism and it was hoped that such altered 
composition may in some cases lead to altered structural and/or regulatory 
properties of the enzyme.
Use of such an approach has produced revertants of citrate synthase 
from E.coli (Danson etal., 1979), A.calcoaceticus (Weitzman etal., 1978) 
and Pseudomonas (Solomon & Weitzman, 1983) with markedly different 
properties from the wild type enzyme.
Three different types of revertant have been isolated from E.coli. One 
produced a ’large’ enzyme with kinetic and regulatory properties similar to 
those displayed by the wild type enzyme. A second also produced a ’large’
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enzyme but unlike the wild type enzyme was not inhibited by 2 -oxoglutarate. 
The third type, however, produced a 'small’ enzyme that was not inhibited by 
2-oxoglutarate nor NADH and displayed hyperbolic rather than wild type 
sigmoidal dependences of rate on the concentration of acetyl-CoA and OAA. 
Such properties more resemble those of the Gram-positive/eukaryotic 
enzyme than the Gram-negative E.coli parent enzyme.
Revertants obtained from A.calcoaceticus also displayed a similar 
array of properties to those from E.coli. One class was a ’large’enzyme that, 
like the wild type enzyme, was inhibited by NADH and reactivated by AMP. 
The other produced a 'small' enzyme that was insensitive to NADH. Once 
again it appeared that an enzyme more resembling that from a Gram- 
positive organism had been produced from a Gram-negative bacterium by 
genetic modification.
All these mutants are thought to be a result of minor genetic changes 
as they were produced by mild mutagenic methods and reverted easily to 
the wild type.
The production of a ’family’ of variant enzymes that mimic the diverse 
forms of naturally-occuring CS have provided us with a valuable tool with 
which to investigate at the molecular level the array of structures and 
regulatory properties observed. It is difficult to make any observation 
regarding structure-function relationships from a study of naturally occurring 
CSs because evolution may well have introduced amino acid sequences 
that do not alter the properties of the enzyme. However, such problems are 
minimised when one investigates variants generated by minor modification 
of the wild type enzyme.
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1.12 Aims of this Work
The aim of this work is, therefore, to create a ’small’ mutant CS from 
E.coli as has been done previously (Danson etal., 1979), to clone the gene 
encoding this enzyme and to sequence the gene in order to identify the 




The bacterial strains used in this work are listed in Table 2.1 A . 
Individual growth requirements are listed in Table 2.1B. K114 was a gift from 
Sir Hans Kornberg (Dept of Biochemistry, University of Cambridge, U.K.).
2.2 Chemicals
Tryptone and yeast extract were from Oxoid Ltd, London, U.K; Agar 
was from Difco Labs, Detroit, U.S.A; CoA and NADH were from Boehringer 
Mannheim, Germany; DEAE-Sephadex and Sepharose CL6 B were from 
Pharmacia LKB, Milton Keynes, U.K.; Matrex Blue was from Amicon, 
Stonehouse, Glos.; Protamine sulphate was from Koch-Light, Colnbrook, 
U.K; CsCI was from Rose Chemicals, London, U.K; Acrylamide, ammonium 
persulphate, 2-mercaptoethanol, sodium dodecyI sulphate and N,N,N',N'- 
tetramethylethylene diamine were from BDH Ltd, Poole, U.K; All radioactive 
isotopes were from Amersham, Bucks., U.K; All other chemicals were from 
Sigma Chemical Company Ltd, Poole, U.K.
2.3 Enzymes
Rabbit IgG conjugated to horseradish peroxidase was from Sigma; All 
restriction endonucleases and DNA modifying enzymes were from 
Northumbria Biologicals Ltd, Cramlington, U.K; Taq polymerase was from 
Perkin Elmer Cetus, Norwalk, USA. Sequenase sequencing kit was from 
United States Biochemical Corporation (Cambridge Bioscience, Cambridge, 
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Table 2.1: Bacterial Strains
B. Growth Requirements
Special Growth Requirements
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2.4 Special Preparation of Reagents
2.4.1 Preparation of Acetvl-CoA
Acetyl-CoA was prepared by the method of Stadtman (1957). 10mg of 
CoA (Boehringer) were dissolved in 1ml water and the solution cooled on 
ice. 0.2ml of 1M KHCO3  were added to bring the pH of the solution to 
neutrality. 5pl of acetic anhydride were added and the solution left on ice for 
at least 10 min. This should give a solution of approximately 7mM acetyl- 
CoA.
Acetylation was tested by reaction with 0.1mM DTNB, 20mM Tris/HCI 
pH 8.0 and monitoring at 412nm. Complete acetylation was achieved if no 
yellow colour developed.
2. 4.2 Equilibration of Phenol
All phenol used was pre-equilibrated to > pH 7.8 to avoid losing the 
DNA in the organic phase. An equal volume of 0.5M Tris/HCI pH 8.0 was 
added to the phenol and the mixture stirred on a magnetic stirrer for 15 min. 
The mixture was allowed to stand until the two phases had separated and 
then the upper aqueous layer was removed. An equal volume of 0.1 M 
Tris/HCI pH 8.0 was added to the phenol and the mixture stirred as before. 
The two layers were again separated and the Tris/HCI extractions repeated 
until the pH of the phenol layer was 8.0 (as measured with pH paper). The 
equilibrated phenol was store at -20 °C under 100mM Tris/HCI pH 8.0 until 
required.
2.4.3 RNAase A
RNAase A that was free of DNAase was prepared by the following 
method. 10mg of RNAase A were dissolved in 1ml 10mM Tris/HCI pH 7.5,
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15mM NaCI. The solution was heated to 100 °C for 15 min and then allowed 
to cool slowly to room temperature. The solution was then dispensed into 
aliquots and stored at -20 °C until required.
2.4.4 Denatured Salmon sperm DNA
A solution of 10mg salmon sperm DNA/ml water was sheared by 
passing through a 19-gauge hypodermic needle several times. The solution 
was stored at -20 °C in small aliquots until required. Just prior to using, the 




3.1 Growth and Maintenance of Bacteria
All bacterial strains were kept at -70 °C.
Growth in liquid media was at 37 °C with shaking.
All media was sterilised by autoclaving prior to use.
Cells were grown routinely in Luria-Bertani (LB) medium (10g bacto- 
tryptone, 5g bacto-yeast extract, 10g NaCI per litre).
Minimal media were based on the basal salts medium of Ashworth 
and Kornberg (1966): 50mM Na/K PO4  buffer pH 7.2 with 50mM NH4CI,
0.18mM CaCl2 , 0.018mM MnS0 4  and 0.014mM FeS0 4 .
Appropriate carbon source, sterilised by autoclaving, and any growth 
requirements, filter sterilised, (Table 2.1 B) were added to the minimal 
medium after autoclaving.
When required, ampicillin was added to the autoclaved medium after 
cooling to 60 °C.
For solid media 1.5g agar/100ml medium were added.
a-complementation was detected by mixing 50pl of 2% (w/v) X-gal (5- 
bromo-4-chloro-3-indolyl-p-D-galactoside) in dimethylformamide and 10pl of 
100mM IPTG (isopropylthio-p-D-galactoside) with the bacterial cells prior to 
plating out.
3.2 Harvesting of Cells and Preparation of Cell Free Extracts
Cells were harvested by centrifugation at 11 OOOg for 10 min at 4 °C.
Cell free extracts were prepared by sonication (Ultrasonics 180W 
sonicator) for 2 min in 15 s bursts with 15 s cooling. When a volume less 
than 10ml was being sonicated, a 3mm probe was used and sonication 
carried out at 50W. For volumes greater than 1 0 ml, a 19mm probe was used 
and sonication carried out at 180W. Cell debris was removed by
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centrifugation in a microfuge at full speed for 5 min or at 5 000 g for 10 min 
for large volumes.
3.3 Assay of Citrate Synthase [EC 4.1.3.7]
Citrate synthase was assayed spectrophotometrically at 412nm,
25 °C according to the method of Srere et al. (1963). Unless otherwise 
stated, the assay mixture contained 20mM Tris/HCI pH 8.0, 1mM EDTA,
0.15mM acetyl-CoA (2.4.1), 0.2mM OAA and 0.1 mM DTNB (5.5’-dithiobis(2- 
nitrobenzioc acid). The CoA produced reacts with the DTNB to form a yellow 
derivative thio-nitrobenzoate (TNBS"). The molar extinction coefficient of 
TNBS" was taken to be 13 600 l.moMcm“1 at pH 8.0 (Ellman, 1959).
3.4 Assay of Lactate Dehydrogenase [EC 1.1.1.27]
Lactate dehydrogenase (LDH) was assayed spectrophotometrically at 
25 °C by measuring the oxidation of NADH at 340nm. Unless otherwise 
stated, the assay mixture contained 20mM Tris/HCI pH 8.0, 1mM EDTA, 
0.2mM pyruvate and 0.2mM NADH. The molar extinction coefficient of NADH 
was taken to be 6  220 l.moMcnrl at pH 8.0. Any non-specific NADH 
oxidation was accounted for by assaying in the absence of pyruvate.
3.5 Assay of Malate Dehydrogenase [EC 1.1.1.37]
Malate dehydrogenase (MDH) was assayed spectrophotometrically at 
25 °C by measuring the oxidation of NADH at 340nm. Unless otherwise 
stated, the assay mixture contained 20mM Tris/HCI pH 8.0, 1mM EDTA, 
0.2mM OAA and 0.2mM NADH. The molar extinction coefficient of NADH 
was taken to be 6  220 l.moMcm"1 at pH 8.0. Any non-specific NADH 
oxidation was accounted for by assaying in the absence of OAA.
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3.6 Estimation of Protein Concentration
Protein concentration was estimated using the method of Bradford 
(1976). To 800jj.I  of sample in 20mM Tris/HCI pH 8.0 was added 200|il of 
BioRad Protein Assay concentrated dye reagent (BioRad Laboratories, Ltd.) 
and after allowing the colour to develop for 5 min, the absorbance was 
measured at 595nm. The values obtained were compared with a standard 
curve of thyroglobulin concentrations.
3.7 Mutagenesis using Ethvl Methanesulphonate (EMS1
Cells from 2 0 0 ml of an overnight culture in minimal medium were 
harvested and resuspended in 20ml of 1 0 0 mM Na/K PO4  buffer pH 7.0. 
200pl of EMS were added and the suspension incubated at 37 °C for 60 
min. 1 ml of the cells were collected by centrifugation for 1 min in a 
microfuge, resuspended in 100|il 100mM Na/K PO4  buffer and spread onto 
glucose minimal media plates.
3.8 Molecular Weight Estimation of Citrate Svnthase
Size differences of revertant CSs was investigated using a Superose
1 2 column connected to a Pharmacia LKB FPLC system. 200pl samples of
cell free extracts were loaded onto the column and the column run in 0.1 M
Tris/HCI pH 8.0, 1mM EDTA and 20% (v/v) glycerol at a flow rate of
0.3ml/min. 0.2ml fractions were collected on ice using a Frac 100 fraction
collector (Pharmacia LKB) and assayed for CS (Method 3.3) using 20% (v/v)
glycerol in the assay mixture. A calibration curve was constructed using a
number of proteins of known molecular weights; the Kd values of the
proteins were calculated using the equation
Kd = Ve-Vx 
Vy-Vx
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Where Ve=elution volume of the protein, Vx=exclusion volume of Blue 
Dextran 2000 (Mr 3x106) and Vy=elution volume of dnp-lysine (Mr 367). The 
Kd values of the CSs were also calculated and compared with the 
calibration curve for an estimation of molecular weight.
3.9 Gram Staining
Gram staining was performed as described by Gillies and Dodds 
(1973). A loopful of bacteria from an overnight culture was spread on a 
microscope slide. The slide was dried in air and the material fixed by 
passing the slide three times through the flame of a bunsen burner. The 
slide was then flooded with Methyl Violet (0.5% w/v) and left for 5 min after 
which it was rinsed with Gram's Iodine (0.3% w/v iodine, 0.6% w/v potassium 
iodide). After a further 2 min, the slide was drained and the cells 
decolourised by exposure to acetone for 5 s before rinsing in water. Neutral 
red (1% w/v neutral red, 1% v/v HAc) was applied as a counterstain, and 
after 30 s the slide was rinsed with water and blotted dry.
3.10 Extraction of Nucleic Acids with Phenol:Chloroform
Phenol was removed from storage at - 2 0  °C, warmed to room 
temperature and then melted at 6 8  °C. The upper aqueous layer was 
removed and an equal volume of chloroform :isoamyl alcohol (24:1) was 
added. To the DNA sample was added an equal volume of this 
phenol:chloroform mixture and the resulting mixture shaken until an 
emulsion formed. The mixture was then centrifuged at 12 000 g for 2 min in a 
microfuge or at 2 000 g for 15 min if a large volume was being extracted. The 
upper aquous phase containing the DNA was removed taking care not to 
disturb the protein interface.
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3.11 Ethanol Precipitation of Nucleic acids
The sample volume was estimated and one tenth of the volume of 3M 
NaOAc pH 5.5 was added. Two volumes of ice-cold absolute ethanol was 
added and, unless otherwise stated, the sample placed at -20 °C until a 
precipitate had formed. Usually 30 min was sufficient. The DNA was 
collected by centrifugation at 1 2  0 0 0  g for 1 0  min in a microfuge or 1 0  0 0 0  g, 
4 °C for 30 min if precipitation was being carried out on a larger volume. The 
pellet was then carefully washed with 70% (v/v) ethanol and dried under 
vacuum.
3.12 Estimation of DNA quantity bv Spectrophotometry
The amount of DNA in a sample was measured by spectrophotometry 
at 260nm. An absorbance of 1 at 260nm corresponds approximately to 50 i^g 
of double stranded DNA and 37pg of single stranded DNA.
3.13 Agarose Gel Electrophoresis
Horizontal submarine gel electrophoresis was used for the analysis of 
DNA. Unless otherwise stated, 1% (w/v) agarose in TBE was heated until 
melted and then allowed to cool to about 60 °C. Ethidium bromide was then 
added to give a final concentration of 0.5pg ethidium bromide/ml. A perspex 
mould with two solid perspex sides was prepared by forming the remaining 
two sides with masking tape and placing a comb about 1cm from one end of 
the mould, making sure that it did not touch the bottom of the mould. The 
cooled agarose was poured into the mould and allowed to set at room 
temperature or at 4 °C if a low melting temperature gel was being used. 
When set, the comb was carefully removed and the gel placed in the main 
apparatus with the wells towards the cathode. The gel was then covered in
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running buffer, TBE containing 0.5pg ethidium bromide/ml, unless otherwise 
stated. The samples were loaded in 15% (w/v) Ficoll, 0.25% (w/v) xylene 
cyanol, 0.25% (w/v) Bromophenol Blue and electrophoresed at 50V, unless 
otherwise stated, until the leading dye was at least three quarters of the way 
down the gel. The DNA was visualised using a transilluminator.
3.14 Isolation of Chromosomal DNA
A 100ml culture of E.coli was grown for 16 h and the cells harvested. 
The supernatant was discarded and the cells resuspended in 40ml TE and 
centrifuged as before. Again the supernatant was discarded and this time 
the pellet was resuspended in 3.22ml of 50mM Tris/HCI pH 8.0, 25% (w/v) 
sucrose. 0.64ml of lysozyme (20mg/ml) was added and the cells swirled 
gently on ice for 5 min. Then 0.5ml of 20% (w/v) SDS and 0.64ml of 0.5M 
EDTA pH 8.0 were added and the cells incubated on ice for a further 5 min. 
2.5mg of proteinase K were added to the lysed cells which were then 
incubated at 45 °C for 30 min. The digested protein in the lysate was then 
removed by phenol extraction (Method 3.10). The aqueous layer was 
removed and the phenol:chloroform layer re-extracted with 2.5ml of TE. The 
aqueous layer was once again removed and pooled with that from the 
previous extraction. The nucleic acids in the aqueous sample were collected 
by ethanol precipitation (Method 3.11) and dried under vacuum. The pellet 
was resuspended in 5ml of TE and the nucleic acid was precipitated again 
with ethanol. The pellet was then washed with 70% (v/v) ethanol and dried 
under vacuum.
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3. 15 Removal of RNA
The dried pellet of isolated DNA from Method 3.14 was resuspended 
in 4.5ml of water. 0.45ml of 20x SSC and 0.25ml of RNAase A (10mg/ml)
(2. 4.3) were added and the mixture incubated at 37 °C for 20 min. The 
digested nucleic acids were then removed by phenol extraction (Method 
3.10). The aqueous layer containing the DNA was removed and the DNA 
collected by ethanol precipitation (Method 3.11). The precipitate was 
resuspended in 2ml of water by swirling on ice. 100 jul of 4M NaCI was 
added and the DNA precipitated and collected as before. The pellet was 
resuspended in 2 ml of water and ethanol precipitated for a third time. The 
purified DNA was washed in 70% (v/v) ethanol, dried under vacuum and 
finally resuspended in 2ml of TE and stored at -20 °C. The quantity of DNA 
was estimated spectrophotometrically (Method 3.12).
3.16 Restriction Endonuclease Digestion
Purified DNA was mixed with the appropriate buffer (diluted 10 fold to 
its working concentration) and restriction endonuclease (1 unit/ i^g DNA) in 
an Eppendorf tube, ensuring that the enzyme made up no more than 10% of 
the final volume. The mixture was thoroughly mixed and incubated at 37 °C 
for 1 h. When double digests were being carried out, the sample buffer was 
then adjusted for the second enzyme, the enzyme added (1 unit/jug DNA) 
and the DNA incubated for a further hour at 37 °C. The samples were then 
analysed by agarose gel electrophoresis (Method 3.13).
3.17 Southern Blotting (Southern, 1975)
After running overnight at 50mA the agarose gel was carefully 
transferred to a large container and incubated in 0.4M NaOH, 0.6M NaCI,
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with gentle shaking, for 30 min to denature the DNA. This was replaced with 
neutralising solution; 0.5M Tris/HCI pH 7.5, 1.5M NaCI, and the gel agitated 
gently for a further 30 min with one change of neutralising solution. 
Meanwhile, a piece of NEN GeneScreen plus membrane (Dupont, U.K.) was 
cut to the same size as the gel. This was then soaked in water for 15 min 
followed by 10 min soaking in 10x SSC. The apparatus was set up as 
shown in Fig. 3.1. Care was taken not to trap air bubbles between each 
layer. Any gel and wicks visible were covered in cling film to prevent short 
circuiting and evaporation of the buffer. The tray was half -filled with 10x 
SSC and the transfer allowed to proceed overnight. The next day the paper 
towels and filter papers were carefully removed from the membrane, which 
in turn was removed and soaked in 0.4M NaOH for 60 s. The NaOH was 
replaced with Tris/HCI pH 7.5 and the filter soaked in this for 10 min with one 
change of buffer. The membrane was removed and air-dried at room 
temperature between Whatman 3MM for 15 min and placed at 37 °C for 30 
min. Finally the membrane was sealed in a plastic bag and kept at -20 °C 
until required.
3.18 DNA labelling
DNA was labelled using a Multiprime kit (Amersham) based on the 
random sequence hexanucleotide priming method (Feinberg & Vogelstein,
1983) using Klenow. 1jug of plasmid DNA was cut with the appropriate 
restriction endonucleases and fractionated on a 1% (w/v) low gelling 
temperature agarose (Sigma) gel (Method 3.13) using 20mM Tris/HCI pH 
8.0, 20mM NaAc, 2mM EDTA, 0.5jug ethidium bromide/ml as the running 
buffer. The band of interest was cut out of the gel with a minimum amount of 
agarose and transferred to a pre-weighed Eppendorf tube. The tube was
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Fig. 3.1 Southern Blotting
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then re-weighed and 3 ml water/g gel was added. The tube was then placed 
in a boiling water bath for 7 min to melt the gel. The sample was then divided 
into aliquots to give at least 25ng DNA per tube and stored at -20 °C until 
required. Prior to labelling the aliquot was re-boiled for 1 min to denature the 
DNA and then placed at 37 °C for 10 min. The DNA was then added to the 
standard Multiprime reaction and labelled for 6  h using [a-3 2 P]dATP. 
Following the reaction, the sample was passed through a spun Sepharose 
CL6 B (Pharmacia LKB) (Method 3.22) column to remove unincorporated [a- 
32p]dATP.
3.19 Measurement of Radioactive Incorporation
1pl of labelled DNA was spotted onto the centre of each of two 2.3 cm 
discs of Whatman DE81 ion exchange paper. One disc was washed three 
times, for 5 min each wash, in 5% (w/v) Na2 HP0 4 , once (1 min) in water and 
once (1 min) in 95% (v/v) ethanol. Both discs were then dried and counted in 
a scintillation counter in Optiphase "Safe" scintillant (Pharmacia LKB).
3.20 Hybridisation
50|il of denatured salmon sperm DNA (2.4.4) was added to 25ml of 
prehybridisation solution (6 x SSC, 5x Denhardt’s solution, 0.5% (w/v) SDS). 
The Southern blot (Method 3.17) was transferred to this solution and pre­
hybridised, with shaking, at 65 °C for 1 h. The denatured labelled probe 
(Method 3.18) was added to the pre-hybridisation mix and the blot 
hybridised at 65 °C overnight. The filter was then washed at 65 °C in 50 ml 
of 2 x SSC for 15 min and then in 50ml of 2x SSC, 0.1% (w/v) SDS at 65 °C 




Fuji RX X-ray film was used for all autoradiography. When filters 
containing 32P were autoradiographed the film was preflashed, an 
intensifying screen was used and the film exposed at -70 °C. When gels 
containing 35S were autoradiographed no preflashing nor intensifying 
screen was required and the film was exposed at room temperature.
3. 22 Spun Column Chromatography
Using a hypodermic needle (19 G) a small hole was made in the 
bottom of a 0.5ml Eppendorf tube. Glass beads (0.5mm) were placed in the 
narrow part of the tube and Sepharose CL6 B (Pharmacia LKB) was added 
to give a column length of about 0.5cm. The small Eppendorf was then 
placed in a 1.5ml Eppendorf and centrifuged at 2 000 g for 4 min. The liquid 
in the bottom Eppendorf was discarded and the small tube replaced in the 
large tube. Two 50jnl aliquots of TE were passed through the column by 
centrifugation as before, the liquid in the bottom tube being discarded each 
time. The column was then placed in a new 1.5ml Eppendorf, the sample 
(<50jlxI) applied to the column and the column centrifuged at 2 000 g for 2 
min.
3.23 Small Scale Plasmid Preparation (Minipreps)
The alkali lysis method of Birnboim and Doly (1979) was used. 10ml 
cultures in LB containing 10Ojug ampicillin/ml medium were grown for a 
minimum of 6  h. The cells were harvested and the supernatant discarded. 
The cell pellet was resuspended in 10Ojul of freshly-prepared 25mM Tris/HCI 
pH 8.0, 50mM glucose, 10mM EDTA. 2mg lysozyme per ml cell suspension
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was added and the cells incubated on ice for 10 min. 200^1 of freshly 
prepared 0.2M NaOH, 1% (w/v) SDS were added and after mixing gently the 
cells were lysed on ice for 10 min. The cell contents were then neutralised 
by mixing with 150 1^ of 3M KOAc/5M HAc pH 4.8 and incubated on ice for 10 
min. After centrifuging at 15 000 g for 2 min at 4 °C the supernatant was 
transferred to a new Eppendorf tube and ethanol precipitated (Method 3. 11) 
on ice for 10 min. After washing and drying, the DNA was resuspended in 
20MlofTE.
3.25 Large Scale Plasmid Preparations (Maxipreos)
500ml cultures in LB containing 100jng ampicillin/ml medium were 
grown overnight. The cells were harvested and then resuspended in 8ml 
25mM Tris/HCI pH 8.0, 50mM glucose, 10mM EDTA. 0.5mg lysozyme was 
added per ml cell suspension and the cells were then disrupted by 
incubation on ice for 15 min followed by the addition of 16ml of 
freshly-prepared 0.2M NaOH, 1% (w/v) SDS and incubation on ice for 30 
min. 12ml 3M KOAc/5M HAc pH 4.8 were added and the cells incubated on 
ice for a further 10 min. Chromosomal DNA was removed by centrifugation 
at 3 000 g 4 °C for 15 min. The supernatant was transferred to clean tubes 
and the DNA precipitated at room temperature by the addition of 0.6 times 
the volume of isopropanol. The DNA was recovered by centrifugation at 10 
000 g 4 °C for 30 min. The DNA pellet was dried under vacuum and further 
purified by caesium chloride density gradient (Method 3.26).
3.25 Caesium Chloride Density Gradient
The dried DNA sample was resuspended in 9.5ml of TE. 9.5g of 
caesium chloride (CsCI) were added and when dissolved, 0.3ml of a
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solution of 10mg ethidium bromide/ml was added. The solution was 
transferred to a heat-sealable tube (Beckman) and filled with a 1g CsCI/ml 
solution. The tube was sealed and centrifuged for 16 h at 200 000 g in a 
Ti70.1 rotor (Beckman). After carefully removing the tube from the centrifuge, 
the lower of the two bands was removed using a hypodermic syringe and 
needle (18G). The ethidium bromide was removed by shaking the sample 
with an equal volume of CsCI-saturated 2-propanol. The upper phase was 
removed and the lower phase was re-extracted with CsCI-saturated 2- 
propanol until no trace of pink remained and then once more. An equal 
volume of water was added to the DNA solution and the DNA precipitated 
with ethanol at room temperature (Method 3.11). After drying, the pellet was 
resuspended in 1ml TE and the quantity of DNA estimated by 
spectrophotometry (Method 3.12).
3.26 Oligonucleotide Preparation
Oligonucleotides were prepared using an automated synthesiser 
(Applied Biosystems) based on the phosphoramidite method (Matteucci & 
Caruthers, 1980; Beaucage & Caruthers, 1981; Matteucci & Caruthers, 
1981). Upon completion of the synthesis, the column was removed from the 
synthesiser and to one end was fixed a 5ml syringe and to the other was 
fixed a 1ml syringe containing 1ml of concentrated ammonia. 0.3ml aliquots 
of ammonia were drawn into the column every 20 min until all the ammonia 
had passed through. The solution was then placed in a screw capped tube 
and incubated at 55 °C overnight. The oligonucleotide was dried under 
vacuum and then resuspended in 1ml water and ethanol precipitated 
(Method 3.11) at -70 °C. After drying under vacuum, the oligonucleotide was
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resuspended in 1ml of water and the quantity estimated by 
spectrophotometry (Method 3.12).
3.27 Amplification of Chromosomal DNA (Saiki efa/,,1985)
Amplification was carried out in a final volume of 100jul containing 
100ng purified chromosomal DNA or 10ng purified plasmid DNA, 10mM 
Tris/HCI pH 8.3, 50mM KCI, 3mM MgCI, 200pl each dNTP, 0.1mM 
oligonucleotides and 2.5 units Thermus aquaticus ( Taq) DNA polymerase 
(Chien etal., 1976) (Perkin-Elmer Cetus). The mixture was overlayed with 
IOOjliI of mineral oil (Sigma) and amplification carried out for 30 cycles in the 
PHC 2 (Techne). The DNA was denatured at 95 °C for 1 min, the 
oligonucleotides annealed for 1 min at 45 °C and the DNA extended at 
72 °C for 1.5 min. 10^ 1 of the reaction mix was analysed by agarose gel 
electrophoresis (Method 3.13).
3.28 Filling in Recessed 3' Ends
To a 20jliI sample of amplified DNA was added 2jnl of 10x NTB (0.5M 
Tris/HCI pH 7.5, 0.1M MgS04, 1mM EDTA, 500ng BSA/ml), 1pl of dNTP mix 
containing each dNTP at 2mM and 1 unit of Klenow. After mixing,the solution 
was incubated at room temperature for 30 min and the reaction stopped by 
the addition of 1jliI of 0.5M EDTA pH 8.0.
3.29 Stickv-End Ligation
A total of 50ng of vector and insert DNA, in the molar ratio 0.5:1, were 
ligated together. The reaction mix (20jul) containing 50mM Tris/HCI pH 7.5, 
10mM MgCl2 , 1mM DTT, 1mM ATP and 1 unit of ligase was incubated at 
room temperature for 4 h. 2jul of the ligation reaction were then diluted ten
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times with TE and this was used to transform competent bacterial cells 
(Method 3.30).
3.30 Competent Cells
A single colony of the E.coli bacterium TG1 was removed from a 
minimal medium plate and used to inoculate 10ml LB. This was grown 
overnight and 0.5ml of this culture was used to inoculate 50ml of LB which 
was then incubated at 37 °C. When the cells had reached early log phase of 
growth they were removed from the incubator and placed on ice for 10 min. 
The cells were then harvested and gently resuspended in 25ml of ice-cold 
50mM CaCl2 - The cells were then incubated on ice for 30 min and 
centrifuged as before. The cells were then gently resuspended in 3ml of ice 
cold 50mM CaCl2 , and kept on ice until required.
3.31 Transformation of Competent Cells
0.2ml of competent cells were dispensed into a chilled Eppendorf 
tube on ice. 20pl of diluted ligation mix (Method 3.29) was added to the cells 
and mixed by inversion. The mixture was then incubated on ice for 30 min. 
The cells were then heat shocked by placing at 42 °C for 90 s and returned 
to ice for 5 min. 1ml of LB was added and the cells incubated at 37 °C 
without shaking for 30 min to allow plasmid establishment. 200pl of 
transformed cells together with 50pl of 100mM IPTG and 10jil of X-Gal (2% 
w/v) were spread onto an LB plate containing 100jig ampicillin/ml and 
incubated at 37 °C. The degree of competence of the cells was measured by 
transformation with 4ng of pUC19 supercoiled plasmid and plating out 250pl 
of the transformed cells. Each colony obtained then represented a 
competence of 1000 transformants/pg DNA.
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3.32 Production of Single Stranded Sequencing Templates from Double 
Stranded DNA
Immediately prior to sequencing, 3-5pg of plasmid DNA in a total 
volume of 20pl were denatured by reaction with 5ul of 1M NaOH, 1mM 
EDTA pH 8.0 for 1 min at room temperature. The alkali was removed by 
spun column chromatography (Method 3.22) using Sepharose CL6B 
(Pharmacia LKB).
3.33 Sequencing
Sequencing reactions were performed using Sequenase version 2.0 
kit (United States Biochemical Corp.) (Tabor & Richardson, 1987) which is 
based on the chain-termination DNA sequencing method (Sanger eta/., 
1977). 10 pi [a-35S]dATP were used in each labelling reaction and the 
termination reactions were carried out at 45 °C to prevent 'pausing’ at sites 
of exceptional secondary structure.
3.34 Denaturing Gel Electrophoresis
An 8% (w/v) polyacrylamide mix was made using Sequagel reagents 
(National Diagnostics) and a 0.4mm-thick gel poured using the sliding plate 
technique. A sharks tooth comb was inserted upside down into the gel and 
the gel allowed to polymerise at room temperature. Immediately prior to 
loading, the sequencing reactions were denatured by heating to 75 °C for 2 
min. The comb was placed in the gel the right way up and 5pl of reaction mix 
were loaded into each well. The gel was run at 1 200V, 30mA for the 
appropriate amount of time in TBE buffer. The top plate was then levered off 
and the gel soaked in 10% (v/v) methanol, 10% (v/v) HAc for 20 min. After 
carefully removing excess liquid from the gel,a piece of Whatman 3MM
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paper cut to size was carefully laid onto the gel and after complete contact 
was made, the paper carefully lifted with the gel stuck to it. The gel was then 
wrapped in cling film and dried under vacuum at 80 °C for 45 min. The cling 
film was removed and the gel autoradiographed.
3.35 Rapid Lvsis Technique
1.5ml of an overnight culture was centrifuged at 12 OOOg for 1 min.
The pellet was immediately resuspended in 150jil of sample buffer (Method 
3.36) by vortexing vigorously. The sample was then placed in a boiling water 
bath for 3 min and the cell debris was then removed by centrifugation at 
12 000 g for 1 min.
3.36 SDS-Polvacrvlamide Gel Electrophoresis
Electrophoresis in the presence of SDS was performed using the 
discontinuous method of Laemmli (1970).
A 10% (w/v) polyacrylamide slab gel was poured and overlaid with 
water. When set the water was removed and a 3.75% (w/v) polyacrylamide 
stacking gel poured on top and a comb placed in the stacking gel. 0.375M 
Tris/HCI pH 8.8 and 0.125M Tris/HCI pH 6.8 were used for the separating 
and stacking gels respectively. Polymerisation was achieved in both cases 
by using ammonium persulphate and N,N,N\N-tetramethylethylenediamine 
(TEMED).
Protein solutions were mixed with loading buffer (0.1 M Tris/HCI pH 
8.9, 1% (w/v) SDS, 10% (v/v) glycerol, 1% (v/v) 2-mercaptoethanol and
0.001% (w/v) Bromophenol blue) and boiled for 5 min prior to loading. 
Molecular weight markers (Pharmacia LKB) were made up according to the 
manufacturers instructions and also boiled prior to loading.
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The gel was run overnight at 50V using 0.025M Tris pH 8.3, 0.192M 
glycine, 1% (w/v) SDS as running buffer.
3.37 Protamine Sulphate Precipitation
Nucleic acids were removed from cell free extracts by treatment with 
protamine sulphate. A 1% (w/v) protamine sulphate solution was added 
dropwise, with stirring, to the cell free extract (1mg protamine sulphate/10 
mg protein) in ice. After addition of the protamine sulphate the extract was 
stirred in ice for a further 30 min. The precipitated nucleic acids were then 
collected by centrifugation at 20 000 g, 4 °C for 30 min.
3.38 Staining and Pestainina Gels
SDS-polyacrylamide gels were stained by shaking for 2 h in 0.1% 
(w/v) Coomassie Brilliant Blue in 30% (v/v) methanol, 10% (v/v) HAc. 
Destaining was carried out in several changes of 30% (v/v) methanol, 10% 
(v/v) HAc.
3.39 Production of Polyclonal Antibody to Citrate Synthase
300jLig of purified CS in 20mM Tris/HCI pH 8.0 were mixed 1:1 with 
Freunds complete adjuvant in glass syringes. A 10 ml test bleed was taken 
from a male rabbit and the CS injected at two intramuscular sites. Two 
boosts of 200jug of CS mixed with Freunds incomplete adjuvant were given 
at days 17 and 28, again at two intramuscular sites. On day 35 a second 
10ml bleed was taken.
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3.40 Removal of Serum from Blood Samples
After removal of the sample the blood was left at room temperature for 
1 h and then at 4 °C overnight to clot. The sample was centrifuged at 2 500 g 
for 15 min at 4 °C. The serum was removed and aliquots kept at -20 °C until 
required.
3.41 Immuno Dot Blots
A piece of nitrocellulose (Schleicher and Schull) was cut to fit in a 
filtration manifold (Schleicher and Schull) and pre-wetted together with a 
filter pad by soaking in water for 5 min. The filter and nitrocellulose, marked 
for orientation, were then placed on the manifold and the manifold clamped 
tightly. A 30jliI sample of antigen, diluted with 70jal PBS, was applied to each 
well and allowed to remain on the nitrocellulose without suction for 30 min. 
Slight suction was then applied for 30 s. The nitrocellulose was removed 
and air dried before staining and detection.
3.42 Western Blotting
A piece of nitrocellulose (Schleicher and Schull) and two pieces of 
Whatman 3MM paper were cut to exactly the size of the polyacrylamide gel. 
These were soaked in transfer buffer, 48mM Tris, 39mM glycine, 20% (v/v) 
methanol (Analar grade), 0.375% (w/v) SDS for 30 min. One of the sheets of 
Whatman 3MM was placed on the anode plate of a semi dry electrophoretic 
transfer cell (BioRad Laboratories). The nitrocellulose was placed on top of 
this, followed by the gel and finally the second piece of Whatman 3MM. Care 
was taken to ensure that no air bubbles were trapped between the layers. 
The cathode was clamped in place and transfer was carried out at 350mA 
for 45 min.
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3. 43 Staining and Detection of Immunoblots
After immunoblotting, the nitrocellulose was washed twice in PBS. 
Non-specific sites were blocked by incubation, with shaking, for 2 h in 3% 
(w/v) BSA in PBS at room temperature. The blot was then incubated 
overnight with serum diluted 1:1000 with 3% (w/v) BSA in PBS. After 
washing the blot four times with PBS, anti-rabbit IgG (whole molecule) 
conjugated to horseradish peroxidase (Sigma) at a 1:5000 dilution in 3% 
(w/v) BSA in PBS, was added. The blot was incubated for a further 2 h at 
room temperature after which time the blot was washed four times in PBS.
Immediately prior to use 10mg 3-3'-diaminobenzidine was dissolved 
in 15ml of 50mM Tris/HCI pH 7.6. 12jliI of fresh 30% (v/v) H2O2 was added 
and the solution added to the blot. After the colour had developed, the 
reaction was stopped by rinsing in PBS.
3.44 Transfer of Proteins for N-Terminal Sequencing
Following electrophoresis by SDS-PAGE (Method 3.37), the gel was 
equilibrated for 15 min in transfer buffer, 50mM Tris, 50mM glycine, 20% 
(v/v) methanol (Analar grade). At the same time a piece of Immobilon 
polyvinylidene difluoride (PVDF) membrane (Millipore) cut to size and two 
pieces of Whatman 3MM paper also cut to size were soaked in transfer 
buffer. The equilibrated gel was placed in contact with the membrane and 
electroblotted for 15 h at 200mA at 4 °C in transfer buffer.
4. PRODUCTION AND SELECTION OF CITRATE SYNTHASE
REVERTANTS
4.1 Introduction
The citric acid cycle is at the centre of metabolism in that it not only 
acts as the final pathway for the oxidation of major foodstuffs, but also 
provides the precursors for amino acid and porphyrin biosynthesis. Citrate 
synthase (CS), has been proposed as the key regulating enzyme in this 
major metabolic pathway and is itself regulated by several factors. This 
diversity in the regulatory properties of CS, probably reflects the different 
physiological demands on the citric acid cycle.
In situations when the cycle is used solely for the production of the 
biosynthetic precursors 2-oxoglutarate and succinyl-CoA, it is these that 
control the level of CS (Weitzman & Dunmore, 1969; Taylor, 1973; Lucas & 
Weitzman, 1975). However, when the cycle is used exclusively for the 
production of energy, such as in strict aerobes, AMP serves as the regulator 
of CS (Weitzman & Jones, 1968). In the majority of cases, however, the citric 
acid cycle performs both an energy producing and biosynthetic role and, 
therefore, does not fall into either of the categories above. In these 
situations the most notable difference in the regulation of CS is the division 
between those sensitive to NADH and those that are apparently unaffected 
by this regulator. This regulation appears to be at the quaternary protein 
structure. That is, that the ’large’ type enzymes from Gram-negative 
organisms are NADH sensitive whereas the ’small’ type enzymes from 
eukaryotes and Gram-positive bacteria are NADH-insensitive. The question 
of what features of the quaternary structure contribute to this diversity need 
to be answered.
Direct comparisons between the protein sequences of the ’large’ and 
’small* type enzymes are of limited value in that evolution may well have 
introduced neutral changes in the protein sequence as well as those that
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alter the enzyme’s structure and regulation. Mutations producing minor 
genetic changes but which result in major structural and regulatory changes 
of the enzyme, have provided an invaluable tool with which to investigate 
the relationship between CS structure and regulation. Danson and 
colleagues (Danson et al., 1979) have already produced a mutant of E.coli 
that produces a ’small’ rather than ’large’ CS. This mutant enzyme differed 
from the wild type enzyme not just at the molecular level but also displayed 
regulatory characteristics that were consistent with a ’small’ type enzyme. 
The aim of the work in this chapter was to recreate this mutant in order to 
investigate it further, at both the protein and molecular biological level.
4.2 Mutation Strategy
The strategy followed that previously used by Harford (1977) to create 
a mutant CS producing strain of E.coli. The parent strain of E.coli used for 
the mutation was K114. K114 lacks CS activity and was derived by mutation 
of E.coli K12.
K114 was mutated by exposure to the alkylating agent ethyl 
methanesulphanate (EMS) for 60 min (Method 3.7). Revertants that had 
regained CS activity were then selected for, by virtue of their glutamate 
auxotrophy, by growth on glucose (10mM) minus glutamate plates. This was 
based on the fact that if CS activity had been restored, 2-oxoglutarate would 
be produced by the citric acid cycle and could therefore be metabolised to 




4.3 Production and Characterisation of a Revertant of K114
4.3.1 Reversion of K114
41 glutamate auxotrophs were obtained after EMS exposure and 
these were individually screened for CS activity. In order to investigate if any 
of these revertants were potentially of the ’small’ type, the effect of 2- 
oxoglutarate on CS activity was also measured, as ’small’ CSs are not 
regulated by 2-oxoglutarate (Weitzman & Dunmore, 1969). 2-oxoglutarate at 
a concentration of 5mM was used in this investigation as this concentration 
has previously been shown to produce virtual total inhibition of the wild type 
enzyme (Danson et at., 1979). 38 of these revertants showed CS activity and 
all these were inhibited by 2-oxoglutarate in the range 56-100% inhibition. 
As glucose has been shown to suppress the levels of CS to virtually zero in 
mutant strains of E.coli (Gray et al., 1966; Else, 1986) it was decided to 
grow the three colonies not displaying CS activity, in minimal medium with 
succinate (10mM) as the energy source. CS activity was now detected in 
these three revertants and was not inhibited by 2-oxoglutarate. K114 failed 
to grow in minimal medium with succinate as the energy source indicating 
that these were true revertants.
4.3.2 Molecular Weight Estimation
Cell extracts of the three revertants whose CSs were not inhibited by 
2-oxoglutarate were then applied to a Pharmacia LKB Superose 12 gel 
filtration column (FPLC) for molecular weight estimation (Method 3.8). The 
cell free extracts were supplemented with 50 pi of LDH (rabbit muscle) to 
serve as a marker. LDH has a Mr -140 000 and, therefore, if the CS under 
investigation was of the ’large’ type (Mr~250 000) it would elute prior to LDH
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from the column and if it was of the ’small’ type (Mr- 100 000) it would elute 
with or after LDH. The fractions were, therefore, assayed for both CS 
(Method 3.3) and LDH (Method 3.4) activity. One of the three eluted prior to 
LDH suggesting that it was of the ’large’ type (Fig. 4.1 A) whilst the other two 
eluted just after LDH indicating that they were of the ’small’ type (Fig. 4.1B). 
The Kd values of these CSs were calculated to be 0.28 and 0.3 which when 
compared with the standard curve (Fig. 4.2), gave estimated molecular 
weights of 118 000 kDa and 110 000 kDa respectively. One of these 
revertants (Mr-1 18 000) was far more stable than the other and was,
therefore, a better candidate for further investigation. This revertant, now 
referred to as K114r4 was further examined to establish whether it had 
characteristics comparable with those reported for previous ’small’ E.coli 
CS revertants.
4.3.3 Kinetic Properties of K114r4
The specific activity of CS from cell free extracts of K114r4 was shown 
to be 0.04 U/mg protein compared with 0.12 U/mg protein for CS from cell 
free extracts of HB101, a wild type E.coli. HB101 was used as the parent 
strain of K114 was unavailable.
CS activity from K114r4 showed hyperbolic dependences of rate on 
both acetyl-CoA and OAA concentrations (Fig. 4.3). The data was analysed 
by a computer program based on the direct linear plot (Eisenthal & Cornish- 
Bowden, 1974) and are presented as half-reciprocal plots (Fig. 4.4). These 
plots give straight lines indicating that the enzyme obeys the Michaelis- 
Menten equation. Analysis of the data gave apparent Km values of 10.9 
(±4.15) jliM and 7.0 (±1.9) juM for acetyl-CoA and OAA respectively. This was 
in contrast to CS from HB101 which displayed sigmoidal dependences of
Fig. 4.1. Elution Profiles of (A) 'large' CS and (B) 'small' CS from a 
Superose 12 gel filtration column. LDH was used as a marker as this has a 
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Fig. 4.4. Hanes Woolf Plot: [S]/v versus [S] for



















Fig. 4.5. Relationship of Reaction Rate (v) Versus [S] for
Citrate Synthse from E.coli HB101
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rate on both acetyl-CoA and OAA concentrations (Fig. 4.5), though the 
sigmoidicity was more pronounced for acetyl-CoA. In addition, S0 .5  values 
obtained from best fits of the data using a computer program based on the 
Hill equation were much higher than those obtained for the mutant enzyme, 
197^M and 94 i^M for acetyl-CoA and OAA respectively.
4.3.4 Regulatory Properties of K114r4
2-oxoglutarate has been shown to be inhibitor of E.coli CS 
(Weitzman & Dunmore, 1969). At a concentration of 2mM, 2-oxoglutarate 
produced 90% inhibition of the activity of the CS from cell free extracts of 
HB101, whereas no inhibition of the enzyme was produced from cell free 
extracts of K114r4. Inhibition (30%) of CS activity from K114r4 was seen 
only when a concentration of 2-oxoglutarate as high as 10mM was used.
In order to investigate the effect of NADH on the revertant CS 
enzyme, contaminating malate dehydrogenase (MDH) had to be removed 
first. MDH cayalses the reaction
OAA + NADH -  Malate + NAD+
Therefore, if present when the effect of NADH on CS was being 
investigated it would remove all the NADH and OAA added. Gel filtration did 
not remove contaminating MDH as it has a similar molecular weight,
Mr~72 000 kDa, as the ’small’ CS. Affinity chromatography using Cibacron
Blue Sepharose (Amicon) was tried as a method for removing the 
contaminating MDH as Cibacron Blue is well known to bind 
dehydrogenases (Thompson & Stellwagen, 1976). Unfortunately, this 
proved unsuccessful as the CS was not recovered under these conditions. 
This was consistent with earlier reported findings (Robinson, 1984). It was, 
therefore, decided to try to determine the effect of NADH on the revertant CS
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in the presence of MDH by using a large excess of both NADH (1mM) and 
OAA (1mM). As these substrates were in excess there would still be 
sufficient present during the time required to assay CS and examine the 
effect of NADH on the enzymatic activity. The amount of NADH present at 
any one time was calculated from the reaction curve of MDH using 6 220
l.mol."1cnr1 as the molar extinction coefficient of NADH at pH 8.0. At a 
concentration of NADH >0.2mM, CS activity from HB101 was inhibited by 
70% whereas no inhibition of CS activity from K114r4 was displayed at this 
concentration of NADH.
4.3.5 Sulohvdrvl Modification
Chemical modification studies using DTNB have shown that thiol 
groups are essential for the catalytic activity of wild type E.coli CS (Danson 
& Weitzman, 1973; Danson & Weitzman, 1977: Duckworth etaI., 1987). 
Moreover, the mutant enzyme produced by Danson et at. (1979) was shown 
to be even more sensitive to thiol modification, being more or less totally 
inactivated after only 1 min exposure to DTNB ([0.1 mM]). OAA ([0.2mM]) was 
shown to provide complete protection of the mutant enzyme against 
inactivation by DTNB. The reaction of the mutant enzyme from K114r4 to 
DTNB was investigated to determine whether it reacted in a similar fashion 
to the mutant enzyme produce by Danson etal. (1979). The enzyme was 
mixed with the standard reaction mixture (Method 3.3) ([DTNB] =0.1mM) but 
without OAA. After 1 min OAA was added and the enzyme activity measured. 
The mutant enzyme reacted very quickly with the thiol modifier as no 
detectable activity was observed after this 1 min exposure to DTNB. Under 
the same conditions, wild type E.coli still retained 92% of its activity after 1 
min incubation with DTNB. That is 0.24 U/mg protein after incubation with
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DTNB compared with 0.262 U/mg protein before incubation. As OAA 
protects the mutant enzyme from inactivation by DTNB, OAA was added to 
the reaction mix prior to DTNB when assaying CS from K114r4.
4.4 identification of K114r4
Because the CS from K114r4 very closely resembled that from a 
Gram-positive organism, it was necessary to verify that the organism still 
retained the characteristics of E.coli, and the growth characteristics of K114.
4.4.1 Test for E.coli
Gram staining and microscopic examination (Method 3.9) of the 
organism revealed the appearance of Gram-negative rods. The organism 
also grew as pink colonies on MacConkey’s agar, on account of lactose 
fermentation, characteristic of E.coli.
4.4.2.Testfor Origination from K114
K114 has an absolute requirement for methionine (20mg/l) and 
thymine (20mg/l) and K114r4 did not grow in minimal medium without 
supplementation with both of these substrates.
4.5 Identification of the CS aene
The gene encoding for the wild type CS is known as the gltA gene 
and has been located on a 3.2kb Hind\\\-EcoR\ fragment (Guest, 1981). 
Chromosomal DNA was first purified (Method 3.14) from the E.coli strains 
K114r4 and HB101. Analysis on an agarose gel (Method 3.13) showed it to 
be all of high molecular weight without contaminating RNA (Fig. 4.6) 
indicating that the method produced good quality DNA. Double restriction
Fig. 4.6. Agarose gel (1 % w/v) electrophoresis of chromosomal DNA from 
K114r4. Size and position of fragments generated by Hind III digestion of X 










digests (Method 3.16) of these chromosomal DNA preparations were carried 
out using Hind III and EcoR I restriction endonucleases. At the same time 
DNA from the plasmd pDB2, (the gl1A gene subcloned into pBR322 
(Bloxham eta/., 1983)), was digested using the same two enzymes to serve 
as a marker of the gltA gene. The digested samples were then run on an 
agarose gel overnight at 50mA. Restriction digests of the DNA from K114r4 
and HB101 with Hind III and EcoR I appeared to give a similar pattern to 
each other (Fig. 4.7A). The overnight gel was transferred to nitrocellulose by 
Southern blotting (Method 3.17). The blot was probed (Method 3.20) using a 
whole CS gene probe made from the 3.2 kb Hind\\\-EcoR\ fragment of 
pDB2 (Method 3.18) and autoradiographed (Method 3. 21).
From the autoradiograph (Fig. 4.7B) the whole gene probe bound to a 
fragment on the K114r4 and HB101 digests at a region that matched the 
cloned 3.2 kb fragment of pDB2 containing thegliA gene.
4.6 Discussion
From these results it would appear that isolation of a revertant of 
E.colithat produces CS, from a strain not displaying CS activity, has been 
successful. Moreover, this revertant exhibits several characteristics that 
immediately distinguish it from the wild type enzyme.
Firstly the enzyme has been shown to be of the ’small’ rather than 
’large’ type of enzyme as produced by the wild type E.coli. The molecular 
weight estimate obtained is comparable with that of other CSs of Gram- 
positive bacteria and eukaryotic organisms (Weitzman & Dunmore, 1969).
The fact that the enzyme is not inhibited by 2-oxoglutarate and NADH 
is also consistent with that found in other ’small’ CSs (Weitzman & Dunmore, 
1969) and distinguishes it from CS found in wild type E.coli.
Fig. 4.7. A Agarose gel (1% w/v) electrophoresis of Hind\\\-Eco Rl 
restriction digests of chromosomal DNA prepared from K114r4 and 
HB101 and plasmid DNA prepared from pDB2 (git A in pBR322). Size 
and position of fragments generated by Hind III digestion of X DNA 
are shown on the left hand side.
Fig. 4.7. B Autoradiograph of DNA samples. Following agarose gel 
(1% w/v) electrophoresis otHind\W-Eco Rl restriction digests of 
chromosomal DNA prepared from K114r4 and HB101 and plasmid 
DNA prepared from pDB2 (git A in pBR322) the DNA was transferred 
to Genescreen plus membrane by Southern blotting. The membrane 
was hybridised with a 32P labelled probe made by Multiprime 
labelling of the git A gene. The size and position of fragments 
generated by Hind III digestion of X DNA are shown on the left hand 
side.
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DTNB reacts with free thiols and it has been demonstrated that chemical 
modification of the wild type CS with this reagent results in a decrease in 
activity and response to NADH (Danson & Weitzman, 1973). The mutant 
E.coli CS created previously was shown to be extremely sensitive to DTNB 
(Danson et at., 1979) and the revertant created here was affected in the 
same way. This could presumably be the result of exposure of essential thiol 
groups normally buried in the wild type enzyme.
In addition Km values obtained in this work are similar to those 
demonstrated in previous work on a mutant CS from E.coli (Danson etal, 
1979) and are significantly different from the wild type enzyme.
From autoradiography results the gllA gene is still intact and located 
on a 3.2 kb /Y/ndlll-EccRI fragment and, therefore, it is speculated that the 
dramatic changes in characteristics of the enzyme have been brought about 
by minor genetic alterations.
Thus, a mutant has been produced from E.coli, presumably by minor 
genetic changes that exhibits characteristics associated with a ’small’ type 
enzyme and, can, therefore, be investigated further to establish any 
structure-function relationships.
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5. CLONING, SEQUENCING AND EXPRESSION OF THE CITRATE 
SYNTHASE GENE FROM E.coli K114r4, K114 and TG1.
5.1 Introduction
The gene encoding CS in E.coli is known as the gltA gene and is 
located at 16.2 min on the E.coli linkage map (Ashworth etal., 1965). The 
gltA gene has been located on an approximately 3.2 kb Hind\\\-EcoR I 
fragment (Guest, 1981) which has been cloned and sequenced (Ner etal., 
1983) (Fig 5.1).
In the previous chapter it was shown that a mutant of E.coli (K114r4) 
has been created that produces a CS more reminiscent of that produced by 
eukaryotes and Gram-positive bacteria than by Gram-negative bacteria. The 
gltA gene of the mutant is still located on a 3.2 kb Hind\11-EcoR I fragment 
suggesting that no major changes, such as deletions, have been made to 
the gltA gene.
In order to identify the nucleotide substitutions responsible for this 
dramatic change in characteristics it will be necessary to clone and 
sequence the gltA gene encoding the mutant enzyme. In addition, K114r4 is 
a slow growing organism and the mutant enzyme is very unstable. Thus, a 
clone containing amplified levels of the mutant gene would facilitate 
purification of the protein and thus permit a more detailed investigation into 
the structure-function relationships of the enzyme.
It follows then that the aim was now to clone the gltA gene from the 
mutant K114r4, to sequence the gene and to compare the sequence with the 
gltA gene from the wild type E.coli.
5.2 Cloning Strategy
The strategy decided upon was to isolate and amplify the gltA gene 




230 240 250 260 270 280 290 300 310
D T K. A K L T L N G D T A V E L D Y L K. G T L G Q D Y I D I
TGATACAAAAGCAAAACTCACCCTCAACGGGGATACAGCTGTTGAACTGGATGTGCTGAAAGGCACGCTGGGTCAAGATGTTATTGATAT
320 330 340 350 360 370 380 390 400
R T L G S K G Y F T F D P G F T S T A S C E S K I T F I D G
CCGTACTCTCGGTTCAAAAGGTGTGTTCACXnTTGACCCAGGCTTCACTTCAACCGCATCCTGCGAATCTAAAATTACTTTTATTGATGG
410 420 430 440 450 460 470 480 490
D E G I L L H R G F P I D Q L A T D S N Y L E Y C Y I L L N
TGATGAAGGTATTTTGCTGCACCGCGGTTTCCCGATCGATCAGCTGGCGACCGATTCTAACTACCTGGAAGTTTGTTACATCCTGCTGAA
500 510 520 530 540 550 560 570 580
G E K P T Q E Q Y D E F K. T T V T R H T M I H E Q I T R L F
TGGTGAAAAACCGACTCAGGAACAGTATGACGAATTTAAAACTACGGTGACCCGTCATACCATGATCCACGAGCAGATTACCCGTCTGTT
590 600 610 620 630 640 650 660 670
H A F R R D S H P M A Y M C G I T G A L A A F Y H D S L D Y
CCATGCTTTCCGTCGCGACTCGCATCCAATGGCAGTCATGTGTGGTATTACCGGCGCGCTGGCGGCGTTCTATCACGACTCGCTGGATGT
680 690 700 710 720 730 740 750 760
N N P R H R E I A A F R L L S K M P T M A A M C Y K Y S I G
TAACAATCCTCGrCACCGTGAAATTGCCGCGTTTCGCCTGCTGTCGAAAATGCCGACCATGGCCGCGATGTGTTACAAGTATTCCATTGG
770 780 790 800 810 820 830 840 850
Q P F V Y P R N D L S G Y A G N F L N M M F S T C E P Y E V
TCAGCCATTTGTTTACCCGCGCAACGATCTCTCCTACGCCGGTAACTTCCTGAATATGATGTTCTCCACGCCGTGCGAACCGTATGAAGT
860 870 880 890 900 910 920 930 940
N P I L E R A M D R I L I L H A D H E Q N A S T S T Y R T A
TAATCCGATTCTGGAACGTGCTATGGACCGTATTCTGATCCTGCACGCTGACXATGAACAGAACGCCTCTACCTCCACCGTGCGTACCGC
950 960 970 980 990 1000 1010 1020 1030
G S S G A N P F A C I A A G I A S L W G P A H G G A N E A A
TGGCTCTTCGGGTGCGAACCCGTTTGCCTGTATGGCAGCAGGTATTGCTTCACTGTGGGGACCTGCGCACGGCGGTGCTAACGAAGCGGC
1040 1050 1060 1070 1080 1090 1100 1110 1120
L K M L E E I S S Y K H I P E F Y R R A K D K N D S F R L M
GCTGAAAATGCTGGAAGAAATCAGCTCCGTTAAACACATTCCGGAATTTGTTCGTCGTGCGAAAGACAAAAATGATTCTTTCCGCCTGAT
1130 1140 1150 1160 1170 1180 1190 1200 1210
G F G H R Y Y K N Y D P R A T Y M R E T C H E Y L K E L G T
GGGCTTCGGTCACCGCGTGTACAAAAATTACGACCCGCGCGCCACCGTAATGCGTGAAACCTGCCATGAAGTGCTGAAAGAGCTGGGCAC 
1220 1230 1240 1250 1260 1270 1280 1290 1300
K D D L L E Y A M E L E N I A L N D P Y F I E K K L Y P N Y  
GAAGGATGACCTGCTGGAAGTGGCTATGGAGCTGGAAAACATOGCGCTGAACGACCCGTACTTTATCGAGAAGAAACTGTACCCGAACGT 
1310 1320 1330 1340 1350 1360 1370 1380 1390
70
D F Y  S G I I L K A M G I P S S M F T V I F  A M A R  T Y G W  
GGATTTCTACTCTGGTATCATCCTGAAAGCGATGGGTATTCCGTCTTCCATGTTCACrGTCATTTTCGCAATGGCACGTACCGTTGGCTG 
1400 1410 1420 1430 1440 1450 1460 1470 1480
I A H W S E M H S D G M K I A R P R Q L Y I G Y E K R D F K  
GATCGCCCACTGGAGCGAAATGCACAGTGACGGTATGAAGATTGCCCGTCCGCGTCAGCTGTATACAGGATATGAAAAACGCGACTTTAA 
1490 1500 1510 1520 1530 1540 1550 1560 1570
S D I K R
AAGCGAT ATCAAGCGTTAATGG--3'
1580 1590
Fig.5.1 Sequence of gltA and predicted protein sequence of E.coli citrate
synthase (Ner etal., 1983)
The single letter amino acid code is as follows: A, alanine; C, cysteine; D, 
aspartate; E, glutamate; F, phenylalanine; G, glycine; H, histidine; I, 
isoleucine; K, lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q, 
glutamine; R, arginine; S, serine; T, threonine; V, valine; W, tryptophan; Y, 
tyrosine.
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containing engineered restriction sites. The inclusion of restriction sites in 
the primers allows the fragment to be cloned directly into a suitable vector 
and by using different restriction sites, ligation of multiple fragments prior to 
insertion is prevented. The amplified fragment was then to be cut using the 
appropriate restriction endonucleases and inserted into the high copy 
number plasmid pUC18 (Yanisch-Perron etal, 1985; Messing, 1983) cut 
with the same enzymes.
pUC18 carries the lacZ gene which is induced by IPTG and is 
capable of a-complementation in lacZ mutants (Ullman etal., 1967), such as 
TG1, giving rise to blue colonies when grown on plates containing the 
chromogenic substrate X-gal (Horwitz etal., 1964). The lacZ gene of pUC 18 
contains a multiple cloning site and insertion of DNA into this site disrupts 
the lacZ gene, abolishes complementation and gives rise to white colonies 
on X-gal plates.
5.3 DNA Amplification
The polymerase chain reaction (PCR) is a powerful technique based 
on the enzymatic amplification of specific regions of DNA from small 
amounts of complex material (Saiki etal, 1985). Repeated cycles of heat 
denaturation of the target DNA, annealing of primers flanking the segment of 
interest and extension of the annealed primers can result in the production 
of several million copies of the desired region (Fig. 5.2).
Although a relatively new technique, PCR has been used extensively 
in the study of eukaryotic systems and to some extent in prokaryotic systems. 
The specificity of the amplification reaction depends upon the sequence 
homology between the oligonucleotide primers and the target region of 
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1983), DNA amplification was an ideal technique to use in order to isolate 
and amplify the mutant gltA gene.
Two oligonucleotide primers, complementary to regions of the gltA 
gene, were made (Method 3.26). The most reliable amplification has been 
shown to be achieved with non G:C rich primers of at least 20 bases 
(Shyamala & Ames, 1989) and this was, therefore, taken into account when 
designing the primers to use for amplification.
Each primer was 21 bases in length and contained two bases 
mismatched with the gltA gene to give an EcoR I site in one and a Hind III 
site in the other. The DNA segment between and including the primers 
consisted of 1 814 nucleotides and contained both putative CS promotor 
regions (Wilde & Guest, 1986) (Fig. 5.3).
Following 30 cycles of amplification of K114r4 chromsomal DNA 
(Method 3.27), one tenth of the sample was analysed by agarose gel 
electrophoresis (Method 3.13) (Fig. 5.4). A single product of the expected 
size (1.8 kb) was formed.
5.4 Cloning the 1.8 kb Amplified Product
50|il of the amplified mix was passed down a Sepharose CL6B 
(Pharmacia LKB) spun column (Method 3.22) to remove excess primers, 
dNTPs, which may interfere with ligation (Higuchi, 1989). The 3' ends of the 
product were then end-filled using Klenow (Method 3.28), and after stopping 
the reaction, the sample was phenolichloroform extracted (Method 3.10) to 
remove the enzyme and passed down another Sepharose CL6B 
(Pharmacia LKB) spun column (Method 3.22) to remove the phenol. The 
product was then digested (Method 3. 16) using Hind III and EcoR I and 
passed down a final Sepharose CL6B (Pharmacia LKB) spun column
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M A D T K A K 
ATGGCTGATACAAAAGCAAAA
E K R D F K S D I K R _
5 ' GAAAAACGCGACTTTAAAAGCGATATCAAGCGTAATGGTTCGATTGCTAAGTTGTAAATATTTTAACCC
H in d  III
3 ' TATACCGTTCGAACTAAAAATA 5 '
GCCGTTCATATGGCGGGCTTGATTTTTATA 3'
Fig. 5.3. Oligonucleotides used for DNA amplification. 
(Mismatches shown in bold type, t indicates initiation of transcription.)
Fig. 5.4. Agarose gel electrophoresis of a 1.8 kb fragment of the git A gene 
generated by DNA amplification of chromosomal DNA from K114r4. Size 
and position of fragments generated by Hind III digestion of X DNA are
shown on the left hand side.
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(Method 3.22) before ligation (Method 3.29) \n\o Hind\\\-EcoR \ cut pUC18. 
The ligated DNA was then transformed (Method 3.31) into freshly-prepared 
competent TG1 cells (Method 3.30). 200^1 aliquots of transformed cells were 
then mixed with X-gal and IPTG (Method 3.2), spread onto LB agar plates 
and incubated overnight. On the basis of colour selection, 49 recombinants 
were obtained.
5.5 Identification of Recombinants
10 white colonies were picked, from which plasmids were purified by 
mini-preparation (Method 3.23) and then digested (Method 3.16) with Hind 
III and EcoR I restriction enzymes. Agarose gel electrophoresis (Method
3.13) of the digests is shown in Fig. 5.5. All the colonies picked contained a 
recombinant plasmid, 9 of which when cut with Hind III and EcoR I gave two 
fragments: one of approximately 2.6 kb corresponding to the pUC 18 
plasmid and one of approximately 1.8 kb corresponding to the amplified 
fragment of the gltA gene. The fragment observed in the tenth clone has an 
insert of approximately 3.6 kb, maybe corresponding to the ligation of two
1.8 kb fragments although every precaution was taken to prevent this 
happening. To ensure that the 1.8 kb fragment was from the gltA gene, 
single digests (Method 3.16) of one of the plasmid preparations were 
prepared using Bgl I and Pvu II restriction enzymes and analysed by 
agarose gel electrophoresis (Method 3.13). These restriction endonucleases 
were chosen for simplicity as they recognise only a few sites on pUC 18 and 
the gltA gene. The results are shown in Fig. 5.6. The fragments generated 
were of the expected size indicating that the correct fragment had been 
amplified and cloned.
Fig. 5.5. The 1.8 kb amplified git A fragment was ligated together with 
Hind III-Eco Rl cut pUC18 and transformed into E.coli TGI. Mini­
preparations of plasmid DNA were prepared from a selection of the resultant 
clones and the DNA was digested with Hind III andEcoR I.
(Lane: 1. pUC 18 digested with Hind \W-EcoR I; 2-11. recombinants). Size 
and position of fragments generated by Hind III digestion of X DNA are
shown on the left hand side.
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Predicted sizes of fragments generated by Bgl I and Pvu II digestion of a 
recomninant containing a 1.8 kb amplified fragment of the git A gene. Sizes
are shown in kb
Fig. 5.6. Agarose gel electrophoresis of Bgl I and Pvu II digests of one 
recombinant obtained from ligation of a 1.8 kb amplified fragment of the 
git A gene with pUC18. Size and position of fragments generated by Hind 
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The DNA amplification and cloning procedures were then repeated 
using chromosomal DNA from E.coli K114 and DNA prepared by maxi­
preparation (Method 3.24) and caesium chloride density gradient (Method 
3.25) of the plasmid pDB2 (the gltA gene cloned into pBR322 (Bloxham et 
al., 1983)). All amplifications and transformations were carried out on 
separate occasions to guard against cross-contamination. 20 white colonies 
were obtained from K114 and 37 from pDB2. Again a sample of 
recombinants (6) from each cloning experiment were digested (Method 
3.16) with Hind III and EcoR I and on examination on agarose gels (Method
3.13) were all found to contain DNA inserts of approximately 1.8 kb.
5.6 Sequence Strategy
Initially, DNA from one of each type of recombinant plasmid was 
purified by maxi-preparation (Method 3.24) and purified further by caesium 
chloride density gradient (Method 3.25). Single stranded templates were 
made (Method 3.32) and the DNA sequenced (Method 3.33) in both 
directions using primers made to both the sense and anti-sense DNA 
strands.
In some instances, DNA amplification has been shown to introduce 
errors in the DNA sequence due to lack of fidelity of the Tag polymerase 
(Saiki etal., 1988; Tindall & Kunkel, 1988; Keohavong & Thilly, 1989; Reiss 
et al., 1990). Thus, when sequencing individual clones of DNA-amplified 
fragments, any point mutations observed could be just one of these errors. 
To overcome this problem, any region found to contain a mutation was re­
sequenced in a further two transformants, as the same error would be 
unlikely to occur in three different clones.
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5.7 Sequence Analysis
When the wild type clone was sequenced, it proved to match the 
published sequence of the gltA gene (Ner et al., 1983) exactly and included 
the 1170 T to G correction as described by Anderson and Duckworth (1987). 
The frequency of nucleotide misincorporation under the conditions used 
here is.therefore, less than 1 in 1 814 bp, a result which compares with those 
studies also finding low misincorporation (Scharf etal., 1986; Loh etal.,
1989; Shyamala & Ames, 1989). The K114 gltA clone was found to contain 
a single point mutation, G to A at position 1392, resulting in the replacement 
of aspartate 362 by asparagine. The same base change was seen in a 
further two clones from the K114 amplification. When the K114r4 gltA clone 
was sequenced a single base change was also observed which was exactly 
the same as that found in the K114 clone. Two further K114r4 clones were 
sequenced in this region and they too contained this base change. As a 
further precaution, a second DNA amplification of K114r4 was performed 
and the amplified fragment cloned as before (5.4). Three of the resulting 
clones were sequenced in the region containing the base change and they 
too contained the same point mutation.
5.8 Expression of the Cloned gltA genes
TG1 and the TG1 clones containing the gltA gene from K114, K114r4 
and wild-type E.coli were grown overnight in 100ml LB containing 100mg 
ampicillin/ml broth. 1.5 ml of the culture were lysed using the rapid lysis 
technique (Method 3.35) and cell extracts were analysed by SDS-PAGE 
(Method 3.36) (Fig. 5.7). Cell free extracts (Method 3.2) were made from the 
remaining culture and assayed for CS activity (Method 3.3). The levels of CS 
in the three transformants were compared with those obtained for TG1
Fig. 5.7. Cell-free extracts of 1 .E.coli TG1 and E.coli TG1 containing git A 
from 2. K114r4, 3. K114, 4. pDB2 were run on an SDS PAGE gel. The 
expression of a protein of approximate subunit Mr 45 000 is indicated by 
the arrow. The relative molecular mass and position of standard proteins are
shown on the left hand side.
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alone. Clones of the 1.8 kb fragment from K114 and K114r4 gave specific 
activities of CS of 0.220 U/mg protein and 0.228 U/mg protein respectively 
which is comparable with that from TG1 alone, 0.243 U/mg protein.
However, CS activity in the wild type clone was 0.657 U/mg protein which 
represents a 3 fold amplification compared with the CS activity of TG1. This 
amplification factor is similar to that reported for other CS clones (Guest, 
1981).
5.9 Complementation of W620
W620, a strain of E.coli lacking CS activity (Reissig & Wollman,
1963), was transformed (Method 3.31) with the K114, K114r4 and wild type 
recombinant plasmids generated above (5.4). As a control the plasmid pDB2 
was also used to transform the cells. Transformants were first selected for 
their ability to grow on LB in the presence of ampicillin (20pg ampicillin/ml 
LB) and then for their ability to grow on succinate minimal medium in the 
absence of glutamate (4.2). As W620 has been shown to revert and regain 
CS activity fairly easily (Else, 1986) it was grown as a control on succinate 
minimal medium plates to distinguish true complementation from reversion.
All transformants grew in the presence of ampicillin indicating that 
transformation had been successful. Colonies appeared on the succinate 
minimal medium plate of W620 containing pDB2 after 48 h, consistent with 
that previously reported (Bloxham etal., 1983). W620 containing the 
amplified wild type gltA gene also grew on succinate minimal medium plates 
but was slower to grow than that containing pDB2 (72h), maybe as a result 
of the lower expression of CS from this construct compared with pDB2 
(Bloxham et al., 1983). However, there was no evidence of growth on plates 
containing untransformed W620 and so it can be assumed that the amplified
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wild type gltA gene was complementing the W620. W620 containing the gltA 
gene from either K114 or K114r4 failed to grow on succinate minimal 
medium plates indicating that the CS produced by this gene was unable to 
compensate for the defect in the W620 citric acid cycle.
5.10 Discussion
The gltA gene that encodes CS was sequenced from K114r4, a 
mutant of E.coli that produces CS with altered catalytic and structural 
properties. The sequence was compared with that of the gltA genes from a 
wild typeE.coli strain and from K114, the parent of K114r4, in order to 
investigate any modifications at the molecular level and thus, gain some 
insight into the diversity of structure-function relationships displayed by CSs.
DNA amplification was used to isolate the git A gene from 
chromosomal and plasmid DNA. A single product of the anticipated size was 
amplified indicating the high specificity of this technique under the 
conditions used.
The cloning strategy used proved to be successful, producing many 
white colonies. On analysing a sample of these all contained inserts, 95% of 
which were of the correct size. Restriction digests of one of these 
recombinant plasmids generated fragments of the expected size confirming 
that the gltA gene had been amplified and cloned successfully.
Some workers have reported that DNA amplification results in a high 
frequency of misincorporation errors (Scarf etal., 1986; Loh etal., 1989; 
Shyamala & Ames, 1989). When the amplified wild type clone was 
sequenced, however, the sequence of nucleotides was found to be identical 
to that published. Given the low error frequency observed, DNA amplification 
was a reliable technique to use as part of the strategy to identify the minor
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nucleotide sequence differences between K114r4 gllA gene and the wild 
type g/tA gene.
When the gliA gene from the mutant K114r4 was sequenced, a single 
mutation was found, namely, the conversion of a G to A at position 1392 
resulting in the replacement of Asp 362 with Asn 362. Interestingly, 
sequence analysis of the gltA gene from K114, the parent of K114r4, 
showed this same base substitution.
Sequence homology has shown that this residue, equivalent to Asp 
376 of pig heart CS, is highly conserved throughout all CSs sequenced so 
far. Moreover, Asp 362 (and equivalent residues) has been implicated, from 
both crystallographic and site-directed mutagenesis studies as a key residue 
involved in the catalytic mechanism of CS (Wiegand & Remington, 1986; 
Handford etal., 1988; Evans et a/., 1989; Kispal et a/., 1989; Alter etal.,
1990; Karpusas etal., 1990; Karpusas etal., 1991).
The course of catalysis by CS can be divided into three consecutive 
partial reactions; enolization, condensation, and hydrolysis. It is proposed 
that Asp 362 is involved in both the enolization and hydrolysis steps of the 
reaction sequence. In the enolization, Asp 362 acts in concert with His 264 
in general acid-base catalysis. His 264 acts as an acid, donating a proton to 
the carbonyl oxygen of the acetyl group of the acetyl-CoA, whilst Asp 362 
acts simultaneously as a base, accepting a proton from the methyl group of 
acetyl-CoA, resulting in the formation of a neutral enol intermediate. 
Condensation of the enol intermediate with OAA is accomplished, again by 
acid-base catalysis. His 305 acts as the acid this time, protonating the 
carbonyl oxygen of OAA whilst His 264 accepts a proton from the hydroxyl of 
the enol intermediate as it condenses with OAA forming a citryl-CoA .CS 
complex. Thus, the proton is recycled, restoring His 264 to the charge state
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these results could only be explained if during the course of evolution the 
Hind\\\ and EcoR I sites had remained intact and there had been no others 
introduced but that the regions homologous to the DNA amplification probes 
has undergone changes such that the probes no longer bound. Further 
characterisation and confirmation that this altered CS is distinct from the gltA 
gene product is required in order to investigate the nature of the CS 
displayed by K114r4.
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6. IMMUNOLOGICAL STUDIES ON THE MUTANT CS FROM K114r4
6.1 Introduction
A mutant of E.coli has been created that produces a CS with altered 
kinetic, regulatory and structural properties compared with the wild type 
enzyme. On cloning and sequencing the gltA gene that encodes for E.coli 
CS a single mutation was found that caused the replacement of Asp 362 
with Asn 362. Asp 362 has been implicated as one of the essential residues 
of CS for catalysis, participating in both enolization of acetyl-CoA and 
cleavage of citryl-CoA (Remington etal., 1982; Karpusas etal., 1990; 
Karpusas etal., 1991). Indeed, site directed mutagenesis involving 
replacement of Asp 362 with several amino acids, including Asn, has shown, 
that without Asp 362, CS is inactive (Handford etal., 1988; Evans etal.,
1989; Alter et at., 1990). This was paralleled in this work as no increased 
activity above the base level was observed in bacteria transformed with 
plasmid containing the K114r4 gltA gene. However, K114r4 does display 
CS activity and, therefore, as the gltA gene appears to have been 
inactivated it is proposed that the protein displaying CS activity must be the 
product of another gene.
Although, most of the proteins of E.coli are of a single molecular 
species encoded by a single gene, there are many instances where two or 
more genes encode for enzymes catalysing the same reaction (Bachman, 
1990). These multiple genes may be either duplications of the same gene 
resulting in the production of closely related proteins or may have arisen 
independently by convergent evolution (Zipkas & Riley, 1975).
A probe made to the 3.2 kb Hind\\\-EcoR I fragment carrying the gltA 
gene only hybridised with one fragment of 3.2 kb after restriction digest and 
Southern blotting of K114r4 chromosomal DNA (4.5). It is, therefore, 
proposed that the gene encoding the altered CS is distinct from the gltA
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gene and that it produces a protein which may be structurally unrelated to 
wild-type CS. To test this hypothesis a polyclonal antibody was raised 
against wild type E.coli CS and used in immunological studies of E.coli 
strains K114, K114r4and HB101.
6.2 Purification of Wild Type E.coli CS
Wild type E.coli CS was purified from the organism DB1002 (Bloxham 
etal., 1983) using a previously developed procedure (Else, 1986) which is 
summarised in Table 6.1. DB1002 is the CS deficient strain of E.coli, W620, 
transformed with the plasmid pDB2 which contains the gliA gene.
2.2g (wet weight) of cells from 500ml of an overnight culture of 
DB1002 in LB containing 100 i^g ampicillin/ml broth were used for the 
enzyme purification. Following treatment with protamine sulphate (Method 
3.37), the extract was applied to a column (30cm x 3cm) of DEAE Sephadex 
(Pharmacia LKB) equilibrated with 20mM Tris/HCI pH 8.0, 1mM EDTA. The 
CS was eluted with a linear gradient of 0 to 0.5M NaCI in 500ml buffer. The 
flow rate was 15ml/h, and 3ml fractions were collected. Fractions containing 
CS with specific activity greater than 20U/mg protein were pooled, and the 
buffer changed to 20mM triethanolamine (TEA) pH 7.3, 1mM EDTA using a 
PD10 column (Pharmacia LKB). The sample was then applied to a Mono Q 
ion exchange column (Pharmacia LKB) connected to an FPLC system 
(Pharmacia LKB). The bound CS was eluted with a linear gradient of 0 to 
0.5M NaCI in 50 ml of 20mM TEA pH 7.3, 1mM EDTA. The flow rate was 
1ml/min and 1ml fractions were collected. Fractions with a specific activity 
greater than 45U/mg protein were pooled and desalted using a PD10 
column (Pharmacia LKB). The sample was then re-applied to the Mono Q 
column and eluted as before.
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VOLUME TOTAL TOTAL SPECIFIC
CS PROTEIN ACTIVITY
(ML) (U) (mg) (U/mg)
SONIC 5.4 224 68 3.3
EXTRACT
DEAE 5 137 5.5 25.1
COLUMN
FIRST 1 78 1.6 49.0
MONOO
SECOND 0.5 40 0.5 79.7
MONO Q







The CS recovered from the final step of the purification had a specific 
activity of 79.7 U/mg protein, which represents a 24-fold purification of the 
cell free extract. This specific activity obtained is similar to that reported from 
previous preparations of pure plasmid-encoded CS, using this method 
(Else, 1986) and others (Duckworth & Bell, 1982; Bloxham etal., 1983; 
Robinson etal., 1983).
Electrophoresis of the purified CS on SDS-PAGE (Method 3.36) gave 
a single band corresponding to a sub-unit Mr~45 000 (Fig. 6.1) confirming its
homogeneity.
6.3 Preparation of a Polyclonal Antiserum Against Wild Type E.coli CS
The purified wild type E.coli CS was used to raise a polyclonal 
antiserum in a rabbit (Method 3.39). Prior to immunisation, a 10ml test bleed 
was taken from the rabbit to act as a negative control. A final bleed was 
made on day 35 and the serum (Method 3.40 from this was used in the 
immunological studies.
6.4 Characterisation of the Antiserum
6.4.1 Inhibition of CS
As polyclonal antibodies recognise multiple epitopes on the surface 
of the antigen, they frequently cause inhibition of the enzyme to which they 
have been raised. This fact was used to monitor the binding of the antibody 
to the wild type and mutant enzymes (6.5).
10pl of a cell free extract (Method 3.2) from E.coli HB101, was 
incubated with either pre- or post-immune serum, both of which were diluted 
500-fold in mM Tris/HCI pH 8.0 for 5 min. The sample was then assayed for 
CS activity (Method 3.2) and compared with the activity of HB101 CS in the
Fig. 6.1. SDS-PAGE of Purified Wild-Type CS
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absence of serum. The pre-immune serum (160 pg/ml assay mixture) did not 
effect the activity of HB101 CS whereas the activity decreased from 0.30 
U/mg protein to 0.019 U/mg protein in the presence of post-immune serum 
(130 pg/ml assay mixture) which represents a 94% inhibition of CS activity.
6.4.2 Immunoblottina
Crude cell extracts (Method 3.2) of HB101 were run on SDS-PAGE 
(Method 3.36) and transferred to nitrocellulose by Western blotting (Method 
3.42). After blocking non-specific sites, the filters were incubated with either 
pre- or post-immune serum diluted 1000-fold. Hybridisation was detected 
using a horseradish peroxidase conjugated anti-rabbit IgG (Method 3.43) 
followed by chromographic development (Method 3.43).
The post immune serum recognised a single protein band of 
Mr-45 000 in cell free extract (Fig. 6.2). No immunoreactivity was observed
with pre-immune serum (Fig. 6.2).
6.4.3 Sensitivity
Samples of decreasing amounts of the purified wild type CS were run 
on SDS-PAGE (Method 3.36) and immunoblotted (Method 3.42). The post- 
immune serum was able to detect 5ng of CS (Fig. 6.3).
When cell free extracts of TG1 transformed with K114r4 were run on 
SDS-PAGE, the mutation appeared to have no effect on the production of 
CS (5.8). Therefore, it seemed inappropriate to investigate the 
immunoreactivity of the mutant protein by Western blot as results would be 
hampered by the presence of contaminating wild type enzyme. It was, 
therefore, decided to investigate antibody binding of the mutant protein after
Fig. 6.2. Western Blot of cell free extracts of E.coli DB1002 with polyclonal
antiserum raised against CS.
(Lane 1. Purified CS; 2. Cell extract; 3. pre-immune serum; 4. post-
immune serum)
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Fig. 6.3. Sensitivity of the Polyclonal Antiserum. Varying amounts of purified 
E.coli CS were Western Blotted and reacted with a polyclonal antiserum 
raised against wi Id-type E.coli CS.
93
94
removing the ’large’ wild type enzyme by gel filtration.
Gel filtration of 200jliI cell free extract (Method 3.2) of K114r4 was 
carried out using a Superose 12 gel filtration column (Pharmacia LKB) 
attached to an FPLC system (Pharmacia LKB) (Method 3.8). 3jul aliquots 
from each fraction were then applied to duplicate nitrocellulose filters by the 
dot blot method (Method 3.41). The filters were then reacted with either pre- 
or post-immune serum (Method 3.43) and immuno-recognition determined 
using a horseradish peroxidase conjugated anti-rabbit IgG (Sigma) and 
chromogenic development (Method 3.43). The procedure was then repeated 
using cell free extracts from HB101 and K114.
No reaction was seen when the filters were reacted with the pre- 
immune serum. Fig. 6.4A shows the HB101 CS elution profile and dot blot 
score. Peak CS activity was observed in.fraction 43 (0.48 U/mg protein) and 
on analysis, immunoreactivity of the fractions mirrored CS activity as 
expected.
Predictably, K114 did not display CS activity in fractions eluted from 
the Sepharose 12 column. However, the immunoblot gave positive results in 
a distribution that matched that of HB101 (Fig. 6.4B). The elution of CS from 
K114r4 was also as expected in that the peak of CS activity (Fraction 51) 
eluted after that from wild type E.coli (Fig. 6.4C). However, the peak of 
antibody binding (Fraction 45) did not coincide with the peak of enzyme 
activity but was more consistent with the results obtained from the wild type 
CS.
6.5 Inhibition of K114r4 CS activity
The ability of the polyclonal antiserum to inhibit CS activity from 
K114r4 was investigated as described above (6.4.1) No detectable
Fig. 6.4. Relationship Between Elution profile of CS from 
Superose 12 column and antibody binding (histogram). Cell free extracts of 
E.coli A. TG1; B. K114 and C. K114r4 were applied to a Superose 12 gel 
filtration column. Fractions were assayed for CS and dot blotted. The dot blot 
was reacted with antiserum raised against wild-type E.coli CS and the 
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decrease in activity was detected in the presence of the anti-CS polyclonal 
antibody (130 pg/ml assay mixture).
6.6 Discussion
Pre-immune serum did not bind to any E.coli proteins indicating that 
this could be used with confidence as a negative control and that any 
reaction seen with the post-immune serum was due to antibody raised 
against E.coli CS. The polyclonal antibody produced showed high 
specificity for CS, recognising only that protein in a complex mixture of 
proteins such as that found in crude cell extracts. Furthermore, the antiserum 
was able to detect as little as 5ng of purified E.coli CS on a Western blot.
When fractions were taken from gel filtration of a cell free extract of 
K114 and reacted with the CS antiserum, it was shown, that although K114 
does not display CS activity, it still produces the protein which eluted from 
the column in a similar volume to the CS from the wild type E.coli. This is 
consistent with the sequence data which showed that the promotor 
sequence of the K114 gltA gene was unaltered and that the only change 
involved the active site residue Asp 362 which is essential for activity. 
Previous work (Alter etal., 1990) has shown that altering the equivalent 
residue in the pig heart enzyme does not effect binding of an anti-PHCS 
monoclonal antibody family.
When fractions from the gel filtration of a cell free extract of K114r4 
were analysed, the peak CS activity did not correspond to the peak of 
antibody binding. The peak antibody binding was observed in fractions 
corresponding to those where wild-type CS activity is normally observed. It 
would appear that as in K114, the normal wild-type hexameric enzyme is 
being produced but is inactivated due to the nucleotide substitution. The
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broad peak of antibody binding reflects the elution of the wild type enzyme. 
No second peak of antibody binding was observed in those fractions 
containing the mutant CS activity. The lack of positive reaction on the dot 
blot together with the fact that the post-immune serum did not inhibit the 
activity of the mutant protein suggests that the mutant protein is distinct from 
the wild type protein
Likewise, other mutants of CS have been shown to be unaffected by 
antiserum raised against the wild type enzyme. Weitzman et al. (1978) 
generated a ’small’ NADH insensitive mutant from A.anitratum which was 
not inactivated by wild type antiserum. Similarly no immuno-cross-reactivity 
was observed between a ’small’ NADH insensitive CS mutant from 
P.aeruginosa and the wild type enzyme (C. Mitchell, personal 
communication).
The results from this and the previous chapters show that a mutant of 
E.coli capable of growth in the absence of glutamate has been created from 
a previously CS deficient strain unable to grow without glutmate 
supplementation. This mutant produces a protein that is capable of 
catalysing the same reaction as CS but displays different kinetic and 
molecular properties compared to the wild type enzyme, differs 
immunologically from the native CS and is not encoded by the gltA gene. 
The question then arises as to the nature of this mutant protein.
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7. PURIFICATION AND N-TERMINAL SEQUENCE OF THE MUTANT
PROTEIN.
7.1 Introduction
By mutating K114, a strain of E.coli deficient in CS activity, revertants 
were selected that had regained CS activity. The majority of these revertant 
CSs displayed wild type characteristics but a few displayed altered 
properties. Further investigation of the CS from one of these revertants,
K114r4, revealed that it bore a striking resemblance to CS produced by 
eukaryotes, namely, a M rJ18 000, insensitivity to 2-oxoglutarate and NADH
and high affinity for the substrates acetyl-CoA and OAA. It was assumed, that 
such altered properties were a result of second site mutations within the gltA 
gene, the structural gene for CS. However, sequence analysis revealed that 
the gltA gene of the revertant possessed only one mutation, which was the 
same mutation as that in the gltA gene of K114: the conversion of G to A at 
position 1392, resulting in the replacement of the key residue Asp 362 with 
Asn. Such a mutation has been shown to result in the loss of CS activity 
(Handford etal, 1988; Evans etal., 1989; Kispal etal., 1989; Alter et al.,
1990) and, indeed, the gltA gene of the revertant was unable to complement 
the CS deficient strain, W620. Therefore, as K114r4 possesses an enzyme 
that is capable of catalysing the condensation of OAA with acetyl-CoA it is 
proposed that the enzyme responsible for this reaction is not a product of the 
gltA gene. Furthermore, this mutant enzyme would appear to be not closely 
related to CS as it shows no immunological cross-reactivity with wild type 
CS antiserum. In order to go some way towards identifying the gene 
responsible for this mutant CS activity it was decided to purify the protein so 
that the N-terminal sequence could be determined. With this information it 
would then be possible to search protein data banks in the hope of 
identifying a homologous protein.
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7.2 Purification of the Mutant CS from K114r4
A mutant E.coli CS displaying properties similar to those of the 
mutant protein in this study has been purified to near homogeneity 
(Robinson, 1984). Attempt to purify the mutant CS obtained in this study 
using this method failed to achieve the level of purification previously 
reported. The method employs a gel filtration step using Sephadex G200 
(Pharmacia LKB) and it was at this stage that problems were encountered. 
The enzyme is very unstable and probably as a result of the dilution effects 
caused by gel filtration all activity was lost at this stage. Addition of glycerol, 
which normally improves stability of the enzyme had little effect, probably 
because of the increased run time due to the higher viscosity of the running 
buffer. It was decided, therefore, to adapt the method used for the purification 
of the wild type enzyme as this method uses ion exchange which is not 
hampered by such large dilution effects encountered in gel filtration.
A summary of the purification is presented in Table 7.1. 42.6g (wet 
weight) of cells from 8 litres of a 48 h culture of K114r4 in minimal medium 
were used for the purification. A cell free extract was prepared by sonication 
and the cell debris removed by centrifugation (Method 3.2). Nucleic acids 
were removed from the extract by treatment with protamine sulphate 
(Method 3.36). The sample was then applied to a column (30cm x 3cm) of 
DEAE-Sephadex (Pharmacia LKB) equilibrated with 20mM Tris/HCI pH 8.0, 
1mM EDTA, 20% (v/v) glycerol at 4 C. The CS was eluted with a linear 
gradient of 0 to 0.5M NaCI in 500ml buffer. The flow rate was 15ml/min and 
3ml fractions were collected. The peak fractions were pooled and desalted 
using a PD 10 column (Pharmacia LKB). The mutant protein did not bind to a 
Mono Q ion exchange column in triethanolamine pH 7.3, further indicating 
that it differs from the wild type enzyme. Instead, it was applied to the Mono
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Q column In 20mM Tris/HCI pH 8, 1mM EDTA, 20% (v/v) glycerol. The CS 
was eluted by a linear gradient of 0 to 0.5M NaCI in 50 ml buffer. The flow 
rate was 1ml/min and 1ml fractions were collected on ice. The peak fractions 
were pooled and the buffer changed to 50mM MES/NaOH pH 5.5, 1mM 
EDTA, 20% (v/v) glycerol using a PD 10 column. The sample was applied to 
a Mono S ion exchange column (Pharmacia LKB) connected to an FPLC 
system (Pharmacia LKB). The bound CS was eluted using a linear gradient 
of 0 to 0.5M NaCI in 50 ml buffer. The flow rate and sample collection was as 
before.
The material recovered from the Mono S column had a specific 
activity of 1.94U/mg protein which represents a 62 fold purification of the 
mutant protein although large losses were incurred. 10% SDS-PAGE 
revealed two bands: a major band of M r 45 700 and a minor band of 
M r50100 (Fig. 7.1).
7.3 Immunoreactivity of the Mutant CS
As the mutant CS had been purified, the immunoreactivity of the 
protein by Western blotting was investigated. 500ng was loaded onto an 
SDS polyacrylamide gel, electrophoresed (Method 3.36), and Western 
blotted (Method 3.42). No immunoreactivity was observed with either band 
of the mutant CS whereas strong reactivity was seen with the wild type CS 
(20 ng) (Fig. 7.2).
7.4 N-Terminal Sequencing
7.4.1 Protein Blotting
20jjg of the purified mutant CS was run on a 12.5% SDS 
polyacrylamide gel (Method 3.36) at 30mA until the first blue dye had
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VOLUME TOTAL TOTAL SPECIFIC
CS PROTEIN ACTIVITY
(ML) (U) (mg) (U/mg)
SONIC 5.4 224 68 3.3
EXTRACT
DEAE 5 137 . 5.5 25.1
COLUMN
FIRST 1 78 1.6 49.0
MONOQ







Table 7.1. Summary of Purification of Mutant Protein from K114r4
Fig. 7.1. SDS-PAGE of the Purified Mutant Protein from K114r4
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Fig. 7.4. Alignment of Citrate Synthase Sequences.
•  residues implicated in catalysis.
Letters below the sequences refer to amino acids conserved in all sequences 
Regions of secondary structure in the pig heart enzyme are indicated by a 





reached the bottom of the gel. The gel was then transferred to Immobilon 
PVDF (Millipore) by electrophoresis (Method 3.44). Following transfer the 
blot was stained by soaking in 0.025% (w/v) Coomassie Brilliant Blue, 50% 
(v/v) methanol, 10% (v/v) HAc for 15 min and destained by soaking in 50% 
(v/v) methanol, 10% (v/v) HAc for 30 min. The blot was stored at -20 °C until 
required.
7.4.2 Microsequencina
The blot, still wet, was sent to Imperial Chemical Industries (ICI), 
Pharmaceutical Division, for microsequencing. Sequencing was carried out 
on an Applied Biosystems 470A gas-phase sequencer coupled to an 
Applied Biosystems 120 phenylthiohydantoin analyser by Janice Young of 
the Biotechnology Department at ICI. Both bands were sequenced and the 
results are shown in Fig. 7.3. Both bands gave the same N-terminal 
sequence and it is assumed that they are products of the same protein. The 
two bands, therefore, probably represent different states of the protein with 
the band of lower molecular weight maybe arising due to degradation of the 
protein.
A search was made of protein databanks using the Seqnet vax 
computer at Daresbury. Two protein data bases were searched: the NBRF 
protein data base using the Fasta program and the SwissProt 17.0 data 
base. No proteins were found with N-terminal sequences that matched that 
of the mutant CS.
7.5 Discussion
The CS from K114r4 had been purified and the N-terminal portion 







Fig. 7.3. N-Terminal Sequences
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properties to Mono Q ion exchange resin indicating that they have different 
charge properties. A Western blot of the purified mutant protein showed no 
reactivity towards an antiserum raised against the wild type CS suggesting 
that the proteins are not closely related.
Searches of protein data bases unfortunately did not reveal the 
identity of this mutant protein. However, this is probably not surprising as 
only 31.6% of the entire E.coli chromosome has been sequenced to date 
(Kroger etal., 1991). Comparison of the N-terminal sequence obtained for 
the mutant protein with other CSs (Fig. 7.4) reveals no obvious similarity. 
However, the N-terminal portions of CSs show the least interspecies 
homology and, therefore, more sequence data are needed before any real 
comparisons can be made.
Fig. 7.2. Immunoreactivity of Wild-type CS and the Mutant Protein 
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The question still remains, therefore, as to the nature of this mutant 
CS from K114r4. There exist several possible explanations.
The first is that the protein is a second species of CS. There are many 
instances emerging from mutation studies of pairs or groups of isoenzymes 
in E.coli that catalyse the same reaction but can be distinguished from each 
other by their kinetic and molecular properties. The genes for many of these 
isoenzymes have been mapped showing the homologous enzymes to be 
products of different genes (Table 8.1). This is in contrast, for example, to the 
isoenzymes of alkaline phosphatase that are encoded by only one gene 
(Garen & Garen, 1963) and are formed by post-translational proteolysis 
(Schlesinger etal., 1975; Nakata etal., 1982). In instances where 
isoenzymes are thought to be a result of gene duplication there should be a 
high level of homology between their sequences. Indeed, the three 
isoenzymes of DAHP synthetase [EC 4.1.2.15] have a high level of 
homology at the N-terminal amino acid sequence (Shultz etal., 1981) and 
comparison of the nucleotide sequence of two of the three genes (aroH and 
aroG) gave rise to high homology (Davies & Davidson, 1982) indicating that 
the two genes have arisen from a common ancestor by divergent evolution. 
However, there are many instances where, as in this study, enzymes 
catalyse the same reaction but are immunologically unrelated (Kotlarz & 
Buc, 1977; Claiborne etal., 1979; Richarme, 1989). This could be because 
genetic changes in the course of evolution have been such that many 
antigenic sites have been lost whilst the active site has remained intact. Or it 
could be that the observed similar functions are a consequence of 
convergent evolution from separate ancestral genes. It is interesting to note 
that one of the enzymes from an enzyme pair frequently resembles the 
eukaryotic form of the enzyme (Waygood & Sanwal, 1974; Daldal, 1984;
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Icho & Raetz, 1983
Morrissy & Fraenkel, 1969 
Morrissy & Fraenkel, 1972
Garrido-Pertierra & 
Cooper, 1983
DeFeyter & Pittard, 1986
Komine etal, 1990
Bachmann & Low, 1980
Table 8.1 Isoenzymes
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Millar etal., 1986; Alefounder etal., 1989; Scofield etal., 1990) as does the 
CS observed in this study.
If there does exist a second structural gene for CS it is most likely to 
have arisen by way of tandem duplication of the gltA gene. Gene 
duplication has been implicated as an important factor in evolution and 
bacterial adaptation (Lewis, 1951; Ohno, 1970; Zipkas & Riley, 1975) and 
has been proposed as a mechanism for the evolution of biosynthetic 
pathways (Veron etal., 1972; Truffa-Bachi etal., 1975; Belfaiza etal., 1986).
Danson etal. (1979) performed transduction experiments with P1 
phage using their mutant CSE.coli as donor and the strain K2-1-4 (F-, gal", 
gltA') as the recipient. These experiments gave a co-transduction frequency 
of the gal and gltA genes of 22%. This positions the mutant CS gene 
36.2 kb (Wu, 1966) or 0.9 min on the genome away from the gal gene. 
However, their transduction experiments were non-directional and thus 
there are two possible locations for the mutant CS gene. As the gltA gene 
maps 0.8 min away from the gal gene (Ashworth etal., 1965) the mutant 
gene could be a modified form of the gltA gene (as suggested by Danson et 
al., 1979) and would, therefore, have to be a different mutant from that in this 
study. This is unlikely because the two mutants display more or less identical 
properties. The second possibility is that the mutant CS is a product of a 
gene 0.9 min upstream from the gal gene and could, therefore, have 
resulted from tandem duplication of the gltA gene followed by mutations 
arising in a change in physical properties of the protein without loss of 
function. Examination of the genes currently mapped in that region (Fig. 8.1) 
does not shed any light on the identity of the mutant CS.
Multiple forms of an enzyme may be required to catalyse the same 
reaction but under different metabolic conditions (e.g isoenzymes of








s s n s r
(cybB)
arA* ™ 





















nag — 1 a  I 
g l n S i * m4’ 
orfi
112
pyruvate kinase, Malcovati & Kornberg, 1969), in different places in the 
same cell (e.g isoenzymes of asparaginase, Cedar & Schwartz, 1967) or at 
different stages of differentiation (e.g isoenzymes of catalase, Loewen et al., 
1985a) or to increase the cellular amount of the enzyme via the gene 
dosage effect (Ikemura & Ozeki, 1983). As yet, there is no evidence that two 
forms of CS co-exist in wild type E.coli. However, under normal conditions, 
the mutant CS has low activity which may be masked by the higher activity of 
the wild type enzyme. Relatively little is known about the mechanism 
controlling the transcription of the gltA gene, although it is known that it is 
induced by aerobic conditions and growth on acetate and repressed by 
glucose and anaerobiosis and that its synthesis is inversely proportional to 
growth rate (Gray etal.,, 1966; Smith & Neidhardt, 1983). Could it be that a 
second gene exists that is induced under conditions different to those for the 
gltA gene and has been mutated such that it is now constituitively produced? 
The mutant protein appears to be under different control as its activity is 
severely depressed in the presence of glucose (this study and Else, 1986).
In addition, it has been suggested that many isoenzyme exist to catalyse 
different pathways (Malcovati & Kornberg, 1969; Garwin etal., 1980;Weiss & 
Edwards, 1980; Stribling & Perham,1973; Loewen etal., 1983; Guest et al. 
1985) and it may be that the mutant CS normally catalyses the glyoxylate 
pathway.
A second possibility is that the mutant CS may somehow be related to 
another enzyme. CS catalyses the condensation of acetyl-CoA with OAA (an 
a-keto acid). Several other enzymes,involved in amino acid biosynthesis 
catalyse a similar reaction (Fig. 8.2) and it has been proposed that these 
may all share a common ancestor (Jensen, 1976). As the catalytic 
mechanism is most probably the same in each case, one could envisage
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that in their native state or by minor modifications this group of enzymes may 
be able to utilise different a-keto acids, albeit to a lesser extent. Indeed, the 
activity of the mutant CS is considerably less than that of the wild type 
enzyme. Several studies have shown that the ability to metabolise novel 
carbon sources is achieved by ’recruiting' existing proteins that catalyse 
reactions similar to those needed (LeBlanc & Mortlock, 1972;Cocks etal., 
1974; Stevens & Wu, 1976; Wu, 1976a,b). Minor mutations that may effect 
the regulation and/or structure of those particular enzymes can then lead to 
adequate utilisation of the new substrate. For example, E.coli lacks the 
ability to grow on D-arabinose but by mutation that alters the specificity of 
induction of enzymes of the pathway of L-fucose catabolism E.coli can utilise 
arabinose as sole carbon source (LeBlanc & Mortlock, 1972).In such a 
mutant D-arabinose was able to induce the fucose enzymes and the broad 
specificity of these enzymes then permitted poor but adequate growth on D- 
arabinose. Similar exploitation of substrate ambiguity has been 
demonstrated in E.coli to acquire other new metabolic functions (Hegemen 
& Rosenberg, 1970). In some mutants the enzymes recruited had known 
functions in E.coli whereas others gained enzymatic activity whose normal 
functions were unknown.
Site directed mutagenesis studies have also shown that substrate 
specificity can be dramatically changed by minor mutations around the 
active site. Insertion of a 14 amino acid oligopeptide into the adenylate 
synthesis domain of E.coli methionyl-tRNA synthetase produced a mutant 
that showed adenylate synthesis activity (Starzyk etal., 1989). In addition, by 
making just three base substitutions the specificity of NAD-dependent 
lactate dehydrogenase from Bacillus stearothermophillus was shifted from 
lactate to malate (Wilks etal. ,1988).
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A third possibility is that the mutant CS is a product of a normally 
silent gene. The most well studied example of such a recruitment of a silent 
unexpressed gene is the ebg (evolved |3-galactosidase) system (Campbell 
etal., 1973; Hall & Hartl, 1974; Hall & Hartl, 1975). The wild type 
ebg operon does not permit utilisation of lactose or other 0-galactoside 
sugars (Hartl & Hall, 1974). However, in E.coli lacZ (|3-ga!actosidase) 
deletion strains, spontaneous mutations occur in the ebg operon that allow 
utilisation of lactose (Campbell etal., 1973, Hall & Hartl, 1974; Hall, 1977). 
Other mutants of ebg have been isolated that allow utilisation of lactulose, 
galactosylarabinose or lactobionic acid (Hall, 1978; Hall & Zuzel, 1980). The 
ebg operon is distinct from lacZ. and the ebg enzyme is immunologically 
unrelated to the lacZ gene product (Campbell etal., 1973; Arraj & Campbell, 
1975). DNA sequence analysis has revealed that only a single base change 
in the ebg repressor gene and one to three base changes in the ebg 
structural gene were responsible for activation and substrate specificity 
(Stokes etal., 1985; Stokes & Hall, 1985; Hall eta/., 1989). Despite their 
functional similarity the ebg (3-galactosidase displays only 33.7% overall 
homology with E.coli |3-galactosidase, although the active site residues are 
highly conserved (Hall, 1989).
Thus there is no simple answer to the possible origin of the mutant 
protein. Further work is obviously necessary in order to identify the protein 
and its metabolic function. As the N-terminal sequence of the protein has 
been determined it will be possible to construct an oligonucleotide probe 
with which the gene may be identified from restriction digests of E.coli 
chromosomal DNA and cloned.
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